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 ABSTRACT 
 
Spatial Dynamics and the Mechanoresponse in CD4+ T Cell Activation 
 
Keenan T. Bashour 
 
The activation of naïve CD4+ T cells by antigen presenting cells is a critical step in the 
response of the immune system to foreign pathogens and in its acclimation to host tissues. 
Activation of naïve T cells proceeds through TCR engagement and is further augmented 
by CD28 costimulation: ensuring T cell survival and conferring numerous functional 
capabilities. The work in this dissertation highlights the spatial and temporal dynamics 
that regulate the initial coupling of CD28 with TCR signaling and also dissects the 
mechanical properties conferred by downstream effectors that are required to relay CD28 
costimulation. 
 
A reaction-diffusion model that describes the spatial regulation of costimulation in 
activating human T cells is developed. The Src kinase Lck, though predominantly 
cytosolic, is an ideal candidate for the coupling of the TCR and CD28 pathways. 
Membrane associations bring Lck in contact with these receptors, where mediation of its 
active state by kinase activity and regulation of its spatial dynamics dictate its capacity to 
integrate early TCR and CD28 signaling. This developed reaction-diffusion model 
focusing on Lck is then extrapolated to mouse cells that do not share similar sensitivity to 
segregation of TCR and CD28 triggering: indicating that while Lck is essential for 
costimulation, it does not confer spatial sensitivity in activating mouse T cells. A 
comparison of human and mouse cells demonstrate underlying differences in the 
 diffusivity of Lck across the membrane and the enrichment of the cytoskeleton at the 
interface. 
 
The role of the cytoskeleton in generating TCR-driven contractile forces is then 
investigated through use of micropillar arrays. This approach also enables the 
quantification of forces generated by T cells during cellular activation. The impact of 
CD28 costimulation on TCR-driven force generation is assessed and noted to increase 
cellular forces by 80% beyond what is induced through TCR triggering. By manipulating 
the presentation of CD28 activation, CD28 is determined to be a mechanoresponsive 
receptor that is not directly responsible for mechanosensitivty. Rather, CD28 mediates a 
change in cellular forces through PI3 kinase, whose inhibition normalizes force 
generation in T cells activated by TCR and those costimulated with TCR and CD28. 
Downstream of PI3 kinase, PDK1 is identified as being essential in both TCR and CD28 
costimulatory force generation; inhibition of PDK1 fully abrogates cellular forces. 
 
Lastly, we qualitatively characterize T cell activation on micropillar arrays, where their 
complex topology reveals a multiphasic behavior during activation. Whereas T cells 
activated on planar surfaces are relatively stationary, T cells activated on micropillars 
slowly migrate towards the base of the array. Forces exerted during this migration are 
substantially greater than those previously measured, and the slow migration leads to the 
characterization of multiple phases and the relocalization of key cellular proteins.   
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I - List of Figures 
  
Figure 1.1. Annual death rates per 100,000 in the United States, from 1999 to 2010. The  
left graph displays the death rates for those younger than 75 years and the right 
graph displays the death rates for those over 85 years. Cancer and cardiovascular 
disease [CVD] are the two most prevalent in the population. Cancer-related deaths 
are marked in red, those from CVD in green and all others in blue. Whereas the 
past decade has seen a decline in both overall death rates and CVD-associated 
deaths, the death rate due to cancer has remained unchanged. Cancer is the most 
prevalent cause of death in the United States in younger populations, as indicated 
in the left graph showing the death rate in those under the age of 75. Source of 
data: CDC. 
 
Figure 1.2. The approach for APC-based vaccination relies on eliciting robust maturation  
ex vivo and the relaying of an immune response to T cells. Important factors, not 
diagrammed, include identification of an ideal subset of APCs, including class 
and maturation, and identifying an effective mechanism of delivery of mature 
APCs to T cells. These two considerations are two of numerous motivating 
factors for migrating to a T cell-based approach. 
 
Figure 1.3. A schematic indicating the numerous pathways available to a naïve CD4+ T  
cell following activation (white arrows). Each of these subsets is hallmarked by 
one or two key cytokines, though numerous situations may arise where T cells 
change their cytokine profile (blue, red, violet, yellow and green arrows). TH 
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subsets Tfh, TH22, TH9 and T-bet+ Treg cells are not mentioned in this discussion, 
though their unique roles further highlight T cell plasticity. 
 
Figure 1.4. (A) A diagram indicating some of the key players involved in CD4+ T cell  
activation by an APC. Interactions of note include the TCR-CD3 complex 
interacting with the MHC class II and the interaction of CD28 with either CD80 
or 86. In this diagram, intracellular T cell complexing of these two receptor pairs 
is mediated Lck, though other Src kinases, including Fyn, are also capable of 
mediating this interaction. (B) A schematic of the T cell IS. The central SMAC 
contains activating factors (ie TCR, CD28), the peripheral SMAC contains 
adhesion factors (ie LFA-1) and distal SMAC is the region where CD45 is 
excluded to limit its role during T cell activation. 
 
Figure 1.5. Segregation of costimulatory signals. (A) Soft lithography is employed to  
localization activating antibodies in desired patterns (left column) and result in the 
distinct localization of the complementary protein (middle and right columns). (B) 
IL-2 secretion by mouse CD4+ T cells is measured on patterned surfaces at six 
hours, and demonstrate that colocalization of antibodies targeting CD3 and CD28 
[CCO] enhance activation relative to TCR triggering alone [CD3]. Presentation of 
these antibodies over a wider area further enhance IL-2 secretion, whether these 
antibodies are segregated by micron scale distances [SEG] or colocalized 
peripherally [PCO].  
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Figure 2.1. Spatial Sensitivity to Costimulation. (A) IL-2 is measured at six hours in  
mouse CD4+ T cells on surfaces that target CD3ε and CD28 in colocalized 
(coloc) and segregated (seg) patterns. With a background composed of ICAM-1 
and BSA (BSA), localizes of CD28 to the periphery of the interface enhances 
secretion. However, when cholera toxin subunit B (CT-B) is used, secretion of IL-
2 is severely curtailed on segregated surfaces. (B) Unlike mouse cells, human T 
cells show reduced IL-2 secretion at six hours upon segregation of CD3ε and 
CD28 signaling. The level of IL-2 secretion is comparable to surfaces that do not 
contain CD28. (C) Staining for active Lck, distinguished by phosphorylation at 
Tyrosine 393 (pLck), shows differences in mouse and human cells on segregated 
surfaces. Whereas mouse cells (bottom) show a relatively homogenous 
distribution, human cells exhibit preferential localization of pLck with sites of 
TCR activation. 
 
Figure 2.2. Diffusion measurement. (A) FRAP is used to measure the diffusion  
coefficient in a mouse T cell. The pre-bleach frame shows the distribution of Lck 
at the surface interface. The subsequent frame shows the result of the subcellular 
photobleach, approximately 1 μm in diameter. The following frames show the 
following timelapse. Scale bar denotes 5 μm. (B) Human T cells show reduced 
mobility relative to mouse cells on homogeneously coated with anti-CD3, anti-
CD28 and ICAM-1. Moreover, CT-B impairs the diffusion coefficient of Lck on 
surfaces. To keep these ligands at a constant concentration between the two 
conditions, the CT-B fraction was replaced with BSA in the (-) control. (C) The 
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diffusion of CD4 was measured and showed similar diffusive properties as Lck. 
CD4 diffusion in human cells was measured at 0.5 ± 0.03 μm 2/sec and 0.26 ± 
0.11 μm2/sec in mouse cells. 
 
Figure 2.3. Cytoskeleton differences in mouse and human lymphocytes. (A) Mouse and  
human CD4 T cells were stained for phosphorylated Lck [pLck] (red) and F-actin 
(green) on planar surfaces coated with αCD3, αCD28 and ICAM-1, revealing 
distinct differences between the two species at 30 minutes. Whereas mouse cells 
contained enrichment of these two proteins at the periphery of the cell and a 
moderately diffuse network in the cell center, human cells contain a dense 
network of both proteins. Treatment of human cells with 1 μm Latrunculin B 
destabilized the actin cytoskeletal, also manipulating the localization of pLck, 
which now shows greater colocalization with F-actin. (B) The intensity per unit 
area of F-actin was greater by a factor of two in human cells than in mouse cells. 
Treatment of human cells with 1 μm of LatB reduced the average intensity of the 
actin cytoskeleton. (C) Human cells show a greater interface area, roughly twice 
the area, than mouse cells. LatB treatment further increases the area of human 
cells. Together, these quantify the degree of cytoskeletal enrichment at the IS in 
human cells relative to mouse cells. 
 
Figure 2.4. LatB desensitizes human cells to micropatterns. (A)  Treatment of human T  
cells with LatB increases the lateral diffusion of Lck along the membrane by a 
factor of 5. (B) Treatment of human T cells with LatB during the first six hours of 
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activation does not significantly affect IL-2 production on colocalized features. In 
the absence of LatB, IL-2 secretion on segregated surfaces is comparable to basal 
activation through CD3 alone. However, LatB treatment substantially increases 
IL-2 production on segregated patterns, bringing secretion levels on par to those 
of colocalized features. 
 
Figure 2.5. Latrunculin B modulates localization on micropatterns. (A) Staining for F- 
actin (green) on segregated patterns of antibodies to CD3ε (red) and CD28 (blue) 
shows a dense homogeneous distribution in untreated cells (top), whereas LatB 
treated cells (bottom) show moderate enrichment of F-actin at the site of TCR 
triggering and a more diffuse network throughout the interface. (B) Staining for 
active Lck on segregated (left) and colocalized (right, shown in purple) features of 
CD3ε  and CD28 both showed predominant colocalization of active Lck at the site 
of TCR triggering in untreated cells (top). However, treatment of cells with LatB 
in both instances resulted in a more even distribution of active Lck along the cell 
interface. 
 
Figure 3.1. T cells exert forces on micropillar arrays (A) A 2D schematic shows the  
typical interaction of a T cell (blue) with the antibody-coated micropillar array 
(red). The displacement due to cellular exertion, δ, is used to calculate the force 
generated as described in Section 3.2. (B) Four time points that correspond to 
discrete phases are numbered and shown in (C). In (1), a cell as it first makes 
contact with the micropillar array.  After initial contact, the cell rapidly spreads 
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(2) while exhibiting minimal contractile force. Cells then initiate force generation 
on the micropillar array (3) by initially applying unsynchronized contractile 
forces, marked by white arrows. Finally, cells reach a stable equilibrium (4) 
where the greatest force exertion occurs along the cell periphery and are oriented 
towards the center of the cell. Scale bar in C4 denotes 5 μm. (C) A plot of T cell 
force exertion over time, where each solid trace represents an individual pillar. 
The blue traces are pillars that are not in contact with the cell, whose ambient 
movements are tracked and used to remove the contribution of ambient drift from 
forces generated. The red traces show the interactions of the cell with individual 
pillars. The dotted cyan line shows the average force exerted on each pillar by the 
cell, whereas the dotted green line represents the total force exerted by the cell, 
scaled by 5 so as not to skew the plot. The total force is measured once the net 
forces have stabilized (here, >1000 seconds). 
 
Figure 3.2. Cellular force exertion across pillar heights. T cell forces were measured  
across a range of pillar heights, 5-8 μm, that represent a four-fold change in 
stiffness. Force per area, indicated in black, was found to be consistent across this 
stiffness range. Likewise, the number of pillars that a cell was in contact with, 
indicated in red, was also conserved across this stiffness range, indicating that 
both force per area and total cellular force were conserved. Data is representative 
of >3 experimental runs. Means are plotted, with error bars representing the 
standard deviations for both force per area and pillars in contact. 
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Figure 3.3. Protein enrichment on micropillars. (A) Cytoskeletal constituents F-actin  
(top, green) and non-muscle Myosin IIA (bottom, green) are stained for in T cells 
seeded on micropillar arrays. The activating coating, antibodies that activate 
CD3ε and CD28 (red) is imaged at the interface of the top of the micropillars with 
the T cell. (B) The active forms of activating factors Zap70 and Lck are stained 
for. Scale bars denote 5 μm. 
 
Figure 3.4. CD28 activation augments cellular forces. This graph describes the role of  
CD28 in mediating TCR forces. Inclusion of CD28 activation, either on the 
coating surface or in solution, equally increases T cell contractile forces. Forces 
measured here represent the total force exerted by a cell through micropillars. 
Pillar contact area is not augmented by the inclusion of CD28, either in solution 
or on the surface, and thus total cell force is proportional to force per area. 
 
Figure 3.5. CD28 modulates cytoskeletal enrichment. (A) Filamin A did not show  
preferential localization on micropillars when the TCR was triggered (top). 
However, Filamin A was depleted from micropillars, in a manner similar to 
Myosin IIA, when CD28 was added to the surface coating (bottom). The relative 
intensities of pillar surface coating, Filamin A and CD45 are tracked along the 
white line in the Merged figures, and the distribution of protein is shown on the 
right. (B) The effect of CD28 activation was measured on Myosin IIA, Filamin A, 
CD45 and F-actin by Pearson correlation. Whereas Myosin IIA distribution was 
unaffected by the inclusion of CD28 activation, Filamin A showed a negative 
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colocalization with the micropillars, indicated by a Pearson value less than 0. 
Moreover, while CD45 was unperturbed, F-actin showed increased localization to 
micropillars in the presence of CD28. 
 
Figure 3.6. PI3 Kinase mediates forces through CD28. CD28-dependent contractile  
forces were tested by selective inhibition of its downstream pathway. PI3 kinases 
were inhibiting using the more selective wortmannin conjugate 17β-
Hydroxywortmannin (HWT), which mitigated the contractile forces generated 
through CD28 but had no effect on cells activated through CD3 alone. Inhibition 
of Akt, which is further downstream of PI3 kinase, with Triciribine (Tric) has no 
effect on cellular force generation. Inhibition of PDK1 with the novel inhibitor 
GSK 2334470 (GSK) abrogated cellular forces entirely, which is denoted by an 
asterisk (*). 
 
Figure 4.1. T cell morphology over time. (A) T cells exhibit multiple distinct 
phases on activating micropillars. The initial contractile behavior where force 
measurements are taken (left) is later replaced by an intermediate phenotype 
(middle), where cells extend filopedial projections to interface with the surface. 
After some time, cells fully relocalize to the base of the array (right):, exhibiting 
an invasive phenotype. Scalebar represents 5 μm. (B) Tracking cell behavior and 
classifying them into these three phases over time shows that the majority of cells 
exit the contractile phase by 8 hours following initial activation. Scale bars denote 
5 μm. Temporal tracking fractions are a weighted average of three experiments. 
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Figure 4.2. Invasive cells are activated. IL-2 measurements from 12 to 13 hours after  
seeding demonstrate that invasive cells are capable of secreting IL-2. The level of 
secretion was comparable between micropillars of 1.7 kPa (5μm) and 0.3 kPa (9 
μm), though both secreted roughly one half of adjacent cells that spread on 
regions of planar PDMS (2 MPa stiffness). 
 
Figure 4.3. The position of the MTOC is tracked and found to be coordinated with the  
movement of the T cell to the base of the array by staining for β-Tubulin (green). 
In contractile cells (left) the MTOC delays in its movement to the site of 
activation, and is located in the region between the mid and upper cell. In invasive 
cells (right) the MTOC relocalizes to the base of the array, and is located between 
the pillar base and mid pillar. White scale bar denotes 5 μm. Change in Z height 
from level to level is roughly 3 μm. 
 
Figure 4.4. Protein redistribution in invasive cells. (A) Staining for TCR activation,  
indicated by phosphorylated Zap70 Y319, shows a relocalization of activating 
signal to the base of the array. (B) Staining for F-actin cytoskeleton showed 
distribution along the cell periphery, with substantial enrichment at the points of 
contact with micropillars. (C) Non-muscle Myosin IIA remains relatively diffuse 
throughout cells, though is physically segregated from the site of F-actin and 
CD45 enrichment along the perimeter. 
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Figure 4.5. TCR activation induces morphological changes. T cells were activated on  
cellular trenches, where the planar top regions were coated via microcontact 
printing with either CD3 (left image, blue) or poly-L-lysine (PLL, right image, 
blue). The base and sides of the trenches were then backfilled with BSA (red) to 
ensure that any behavior pertaining to the trenches would be motivated by 
topology rather than protein interactions. Cells that with activated with CD3 
±CD28 extended filopedial protrusions into these trenches, as indicated by an 
actin stain (green). However, cells that were coated on PLL did not exhibit similar 
protrusions. 
 
Figure 4.6. Measurement of bmDC forces (A) A representative image of a bmDC  
generating forces on 5 μm pillars, along with (B) the accompanying brightfield 
image. (C) Measurement of bmDC forces across pillars of different spring 
constants demonstrated a behavior similar to T cells, where force generation 
rather than pillar displacement was consistent.  
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Chapter 1 - Introduction 
 
 
1.1 Cancer and Immunity  
Healthcare costs in the US are growing, both in part to an aging population and also due 
to the increase in new treatment costs. Cancer accounts for roughly $100 billion in direct 
costs: second only to the $300 billion cost of cardiovascular disease [CVD] care [1].  The 
difference is that CVD treatments have been largely successful and has been integral to 
the increase in overall life expectancy. As the overall death rate and the death rate for 
CVD decreases year over year, the cancer-associated death rate has remained relatively 
constant (Figure 1.1). Moreover, cancer is becoming increasingly responsible for 
mortality in younger generations (Figure 1.1). Cancer prevalence is on the rise, 
motivating research into new treatment strategies [2]. 
 
Though there has been substantial effort and funding for cancer research, the moderate 
pace of improvement in therapies is not without reason. Cancer is a heterogeneous 
disease, the complexity of which is well-captured in a pair of articles published in 2000 
and 2011 by Douglas Hanahan, where he describes a paradigm of discrete traits that a 
tumor must acquire in order to be malignant [3, 4]. Together these two articles provide an 
interesting metric to assess new insights glean from the past decade of cancer research. In 
the more recent article, Hanahan points to two previously overlooked features of tumor 
progressions: the proactive reallocation of energy metabolism and the tolerization of 
immune cells to tumor progression. The latter facet, the attenuation of an immune 
response, is a feat that few pathogens can sustain for more than a few weeks. The fallout 
of this revelation has been a number of compelling approaches to reeducate the immune 
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system. Nascent ambitions to reeducate the immune system stem from the field of 
vaccination. Approaches to more directly mature the immune system have slowly begun 
to manifest into its own discipline, encompassing a variety of techniques that are 
collectively referred to as adoptive immunotherapy. 
 
 
Figure 1.1. Annual death rates per 100,000 in the United States, from 1999 to 2010. The left graph displays 
the death rates for those younger than 75 years and the right graph displays the death rates for those over 85 
years. Cancer and cardiovascular disease [CVD] are the two most prevalent in the population. Cancer-
related deaths are marked in red, those from CVD in green and all others in blue. Whereas the past decade 
has seen a decline in both overall death rates and CVD-associated deaths, the death rate due to cancer has 
remained unchanged. Cancer is the most prevalent cause of death in the United States in younger 
populations, as indicated in the left graph showing the death rate in those under the age of 75. Source of 
data: CDC 
 
1.2. Adoptive Immunotherapy 
 The immune system is responsible for detecting and neutralizing pathogens: a task it 
performs through numerous intermediates. There is, however, the persistent concern of 
collateral damage to native tissues. The precarious balance of recognizing foreign 
pathogens while not endangering normal cellular processes manifests in circumstances 
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where the immune system fails in one of these two primary tasks. A failure in targeting a 
valid antigen leads to proliferation of undesired cells, whereas an unintended response 
against native tissue leads to autoimmunity. As a treatment strategy, for potentially both 
chronic infection and autoimmunity, there has been a hope of harnessing and directly 
controlling immune cells (Figure 1.2). This process, known as adoptive immunotherapy, 
was first conceptually validated in 1957 but did not see FDA approval for therapeutic use 
until 2010 [5]. What 50 years of research and over 100 clinical trials employing adoptive 
immunotherapy have taught us is that we have only begun to understand the complex 
process through which an immune response is elicited. The majority of these clinical 
attempts to reeducate the immune system failed to establish a presence that persisted for a 
sufficient timescale to be effective, suggesting that while we have identified many of the 
key cellular and protein players, we have yet to understand the significance of their 
interactions. To more effectively develop robust and tailored therapies necessitates a 
mechanistic approach in understanding how an immune response is relayed from one cell 
to another. 
 
Historically, clinical attempts to harness the immune system have relied on antigen-
presenting cells [APC]. These early trials were seen as a recapitulation of an immune 
response to a vaccine that was executed ex vivo, leading to the early classification as a 
therapeutic vaccine: one that is delivered in a non-prophylactic manner1. Of the APCs, 
dendritic cells [DC] are the ideal vector, due in large part to their high plasticity, capacity 
to activate both CD4+ and CD8+ T cells, established markers indicating immature and 
                                                 
1 With the increase in opportunities and application of vaccine-strategies, these terms have been further 
refined to include subclasses, such as pre and post exposure prophylactic vaccines, and additional new 
classes such as adjuvant vaccines. 
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mature states and their unique ability of cross-presentation. Considerations for adoptive 
immunotherapy are still multifaceted; current variables include the type of immune cell 
used to modulate a response, the maturation state of the cell, the method used to isolate 
and mature cells, the number of cells per transfusion, the route of administration, 
  
 
Figure 1.2. The approach for APC-based vaccination relies on eliciting robust maturation ex vivo and the 
relaying of an immune response to T cells. Important factors, not diagrammed, include identification of an 
ideal subset of APCs, including class and maturation, and identifying an effective mechanism of delivery of 
mature APCs to T cells. These two considerations are two of numerous motivating factors for migrating to 
a T cell-based approach. 
 
the number of transfusions and latent time between transfusions [6-8]. In the interest of 
increasing the fraction of cells that successfully migrate to lymph nodes to active 
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downstream cells, other studies have looked to artificially mature DCs in vivo [9, 10]. 
The sheer number of considerations and any associated interdependencies has 
complicated previous attempts to use DCs as a medium for immunotherapy. The diversity 
in clinical design that all aim to optimize these considerations has complicated a meta-
analysis of the endpoints that could help in identifying key parameters. Ultimately, the 
complexity of APC manipulation has led to conceptually sound yet practically ineffective 
therapies. This disparity was dogmatized as a failure to translate scientific merit into 
clinical endpoints; though DC transfusions showed persistence of transfused cells, tumor 
metastases were not greatly diminished, and the best cases demonstrated a lack of further 
metastasis and primary tumor growth: neither endpoint being positively reflected by 
Response Evaluation Criteria in Solid Tumor [RECIST] guidelines. These attempts 
culminated with a single clinical success, Provenge, though it has had questionable 
commercial success as regulatory boards and insurance companies continue to question 
whether its marginal efficacy over current therapies justify the exorbitant cost of a 
personalized therapy.  
    
Currently, DCs remain an attractive medium to modulate an immune response. However, 
new technologies such as monoclonal antibodies and chimeric antigen receptors [CARs] 
are supplanting the role of the APC, enabling the activation of T cells in a process that is 
free of APCs. Migrating to a T cell-based therapy mitigates many of the concerns 
regarding APCs previously mentioned: in particular, the requisite for substantial 
migration to lymphatic tissues, where naïve T cells await activation. However, a T-cell 
based therapy also necessitates a more controlled approach, as the APC must be emulated 
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in vitro. This aspiration requires a depth of understanding on the activation process 




1.3. The CD4+ helper T cell 
In the context of immunotherapy, T cells provide a compelling cell therapy. The role of 
CD4+ T cells, also referred to as helper T cells, can best be described in juxtaposition to 
CD8+ cytotoxic T cells [CTL]. Whereas CTLs are characterized by their capacity to 
directly engage pathogens, helper T cells take an indirect approach to immunity. CD4+ T 
cells instead focusing on tasks such as cytokine secretion and immune cell interactions to 





Figure 1.3. A schematic indicating the numerous pathways available to a naïve CD4+ T cell following 
activation (white arrows). Each of these subsets is hallmarked by one or two key cytokines, though 
numerous situations may arise where T cells change their cytokine profile (blue, red, violet, yellow and 
green arrows). TH subsets Tfh, TH22, TH9 and T-bet+ Treg cells are not mentioned in this discussion, though 
their unique roles further highlight T cell plasticity. 
 
To facilitate its role in crafting an adaptive immune response, naïve T cell plasticity 
enables numerous viable pathways. Initially, two CD4+ subsets, Th1 and Th2, were 
characterized as mature derived states resulting from cellular activation; these two 
phenotypes were found to respectively enhance cellular immunity and humoral immunity 
[11, 12]. Both responses are potent and are in line with the role of CD4+ T cells as 
facilitating in a coordinated response with other immune cells. Later, two additional 
subsets, Th17 and Treg, were also found to derive from activation, though these two CD4+ 
subsets are tautologically named for respectively augmenting inflammation via IL-17 
secretion and immunoregulation [13, 14]. Mounting evidence has more recently 
demonstrated that T cell plasticity occurs in these mature subsets, and that commitment to 
one of these pathways was not irreversible; rather, crossover between different roles and 
surface expression of receptors indicative of numerous subsets was not uncommon 
(Figure 1.3) [15]. This plasticity is not always advantageous; many Th1 and Th2 T cells 
lose function when in the presence of Treg cells and through mechanisms used to suppress 
an immune response, Tregs can tolerize these cells to a neighboring tumor [16, 17]. An 
understanding of the dynamics involved in CD4+ T cell post-activation plasticity would 
be advantageous in either preventing or directing the direction of T cell fate and function. 
Moreover, what effects cellular activation may have on cell plasticity are still under 
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investigation. A deeper understanding of T cell activation would facilitate these studies. 
 
1.4. Immune Synapse kinetics 
T cell activity is initiated by successful contact and education by an APC. The interface 
between these two cells, the immune synapse [IS], is the site where extensive information 
is relayed between a T cell and its activating APC (Figure 1.4 A). Its highly regulated and 
structurally complex method for directing T cells towards one of its multifarious fates is 
mediated by the synchronization of interrelated proteins. The epicenter of the interaction 
is the presentation of an antigen by the major histocompatibility complex [MHC] on the 
APC to the aptly named T cell receptor [TCR] on the T cell. Receptor engagement is 
followed by central clustering of MHC and TCR molecules in the APC and T cell 
respectively. Other surface molecules either centrally migrate along with these two or are 
segregated to the periphery of the interaction, leading to the formation of spatially 
discrete zones of supramolecular activation clusters [SMACs] that resemble a bull’s eye 
pattern (Figure 1.4 B). In a mature synapse, receptor zone correlates with ectodomain 
size, where the receptors with the larger ectodomains are pushed to the peripheral SMAC 
[pSMAC] and those with smaller ectodomains localize to the central SMAC [cSMAC]. 
Movement occurs in discrete bundles, or microclusters, that are often comprised of 
multiple receptors. On the T cell surface, TCR-MHC complexes migrate to the central 
region of the bull’s eye, or central supramolecular activation cluster [cSMAC]. 




Figure 1.4. (A) A diagram indicating some of the key players involved in CD4+ T cell activation by an 
APC. Interactions of note include the TCR-CD3 complex interacting with the MHC class II and the 
interaction of CD28 with either CD80 or 86. In this diagram, intracellular T cell complexing of these two 
receptor pairs is mediated by Lck, though other Src kinases, including Fyn, are also capable of mediating 
this interaction. (B) A schematic of the T cell IS. The central SMAC contains activating factors (ie TCR, 
CD28), the peripheral SMAC contains adhesion factors (ie LFA-1) and distal SMAC is the region where 
CD45 is excluded to limit its role during T cell activation. 
 
of the accepting T cell to either target the presented antigen, as is the case with positive 
costimulation by CD28, or to tolerate the antigen, which occurs with CTLA-4 mediated 
antagonism. These two receptor pairs both rely on activity of downstream constituents, 
including Src kinases and Phosphatidylinositol3-kinases [PI3K], to propagate their 
influence on T cell fate. How costimulation is mediated through intermediaries is critical 
in the harnessing of an immune response to target disease.  
 
In addition to the competing dynamics that occur within the T cell, there are a number of 
APCs that are capable of directing T cell activation, including B cells, macrophages and 
DCs. The junction of a T cell with each of these APCs results in a distinct IS which 
10 
 
differentially directs the programming and ultimate function of the T cell. Of these 
potential APCs, DCs are the most robust and perhaps the best understood, though work 
exploring their interfacing with T cells has only begun in the past few years [18, 19]. A 
change in the APC or the antigen it presents is known to direct T cell fate; what is 
responsible for this change and the role of the IS in this process is still being studied. In 
addition to the intracellular biomechanics that drive T cell activation, it has been 
postulated that the mechanical properties of these different APCs may drive cellular 
activation. In this context, we explore the mechanical response of T cells to activation, a 
process that while beginning with transmembrane domains located at the cell surface, is 
largely dependent on the underlying cytoskeletal structure. A study into the mechanics of 
the cytoskeleton during activation will facilitate a mapping of an IS-driven T cell 
mechanoresponse.  
 
1.5. Cellular Activation and the Role of Spatial Interplay 
Receptors segregate into the mature IS based on ectodomain size, facilitating sustained 
interactions of receptor pairs that would otherwise be sterically impaired. Though the 
function of the IS relies on differences in ectodomain size, its formation and sustainment 
is driven by intracellular dynamics. However, the formation of a mature synapse is not a 
requisite to trigger downstream signaling, particularly as the time course for IS formation 
does not appear to coordinate with other events critical for T cell activation, including 
TCR crosslinking, Ca+2 flux, and tyrosine phosphorylation  [20]. Microclusters of TCR, 
submicron vesicles containing roughly 30-300 TCR molecules form prior to their 
migration to and eventual formation of the cSMAC, implicating their role in the initiation 
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of downstream signaling [21, 22].  Moreover, the comigration of CD28 with TCR in 
microclusters suggests that the fundamental components necessary to polarize a cellular 
response to positive costimulation are already in spatial proximity prior to mature IS 
formation [23]. The reorganization of these microclusters to the hierarchical mature IS is 
a process that is understood to be driven by the cytoskeletal network; however, the 
mechanism for this process is still a subject of study.  
 
Numerous research groups, including our own, have employed soft lithography to control 
the spatial localization of activating signals in artificial synapses as a method of resolving 
the role of spatial proximity (Figure 1.5 A) [24-26]. This work has demonstrated that the 
relative positions of TCR and CD28 within the synapse impacts high-level function, 
measured by the translocation of NF-κB and the secretion of the cytokine IL-2 [24].  In 
an effort to further resolve the complexity at work, as well as to develop more relevant 
preclinical models, preliminary studies in our research group have revealed differential 





Figure 1.5. Segregation of costimulatory signals. (A) Soft lithography is employed to localization 
activating antibodies in desired patterns (left column) and result in the distinct localization of the 
complementary protein (middle and right columns). (B) IL-2 secretion by mouse CD4+ T cells is measured 
on patterned surfaces at six hours, and demonstrate that colocalization of antibodies targeting CD3 and 
CD28 [CCO] enhance activation relative to TCR triggering alone [CD3]. Presentation of these antibodies 
over a wider area further enhance IL-2 secretion, whether these antibodies are segregated by micron scale 
distances [SEG] or colocalized peripherally [PCO].  
  
T cells from mouse and human sources.  In particular, whereas mouse T cells 
demonstrate an ability to integrate costimulatory signals across artificially engineered 
micron scale regions, human T cells fail to integrate costimulatory signals across 
comparable distances. This disparity presents an opportunity to better characterize the 
role of spatial organization in cellular activation, as well as to identify the underlying 
mechanisms in which spatial sensitivity is differentially conferred in the two species. The 





1.6 Cellular Adhesion and Force Generation during Cellular Activation 
One of the approaches that has been used to resolve the process of IS formation is the 
simulation of the APC with a planar lipid bilayer that is supported on a glass surface and 
contains the fundamental components for initiating T cell activation. In a set of 
experiments where actin velocity was tracked during synapse formation, Yu et al. 
demonstrate that centripetal actin flow reduces in speed when passing confined TCR 
cluster regions [27]. The lack of a complete halt in speed does suggest that there are no 
strong interactions between the TCR and actin, and the reduction in speed is consistent 
with a model that has transient interactions.  The source of this actin has previously been 
identified to be retrograde flow from lamellipodia that eventually depolymerizes upon 
reaching the center of the synapse [28, 29]. This change in actin retrograde velocity is 
one metric for identifying the role of the cytoskeleton though ultimately proves difficult 
to establish for direct quantification. In addition to transient changes in actin flow, 
numerous microclusters, some distinct from TCR clustering, have also been found to 
associate with this actin retrograde flow [19, 21, 30]. It is compelling to consider that the 
degree of centripetal motion of these clusters may be correlated with their relative extent 
of association to the actin cytoskeleton: those that migrate further inwards having a 
greater association whereas those that experience little migration have a weaker 
association. Future work along this direction may yield insights into the nature and 
mechanism of cytoskeletal associations with IS microclusters. 
 
Research endeavors from other groups have looked to quantify the total force exerted by 
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cell upon TCR triggering [31]. Husson and colleagues examine the coordination of 
cellular force generation and other early components of cell activation, including calcium 
flux and actin relocalization. Though demonstrating that TCR triggering does indeed lead 
to force generation, the method of analysis resulted in a single, bulk metric for a pushing 
or pulling force. Moreover, the contact area was restricted to 2.8 μm, the size of antibody-
coated bead used to probe cellular forces. More recently, Ueda and colleagues have 
shown that T cells extend numerous invasive filopedial structures that penetrate deeply 
into activating APCs [32]. Though their work utilized fixed cells measured through 
electron microscopy, these protrusions suggest that force generation is dynamic. 
Evaluating cellular force exertion as a single metric makes for an adequate initial 
estimation of T cell mechanics; however, more fine-tuned techniques are needed to probe 
the underlying mechanisms at play during cellular activation.  
 
The work presented in this thesis will more directly quantify the forces that the 
cytoskeleton generates during cellular activation, looking to assess the total force exerted 
by a T cell while also retaining resolution of local forces. By exploring both the global 
and local forces triggered by APC-based activation, there is great opportunity to ascertain 
behavioral trends during the activation process. Resolving these aspects will lay the 
groundwork for identifying what cellular constituents are involved in the multifaceted 
process of T cell activation. Specifically, this system will be applied in a study of CD28 
and its contribution to force mechanics upon integration with TCR signaling. 
 
1.7. Cancer Dissemination 
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A robust immune response requires policing of all regions of potential host infection. 
Thus, a large number of leukocytes must routinely transverse into peripheral tissues to 
identify or target pathogens. Other than a small number of exceptions, leukocytes can 
penetrate vascular and peripheral tissues with relative ease. This phenomenon has come 
to light when studying the metastatic properties of cancer cells, whose migratory patterns 
do not follow the canonical migratory pattern documented for fibroblast cells.  It has 
instead been proposed that certain cancer cells emulate leukocytes when migrating across 
epithelial membranes. Even our most well-articulated categorization for a phenotype 
cancer exhibits a strikingly wide degree of genotypic heterogeneity. Thus, a deeper 
understanding of the migratory models for both fibroblasts and leukocytes, including a 
comparison of similarities and differences, is critical. To this effect, we propose to 
develop a reproducible and robust system to study the transmigration of leukocytes.  
Initial work will focus on behavioral characterization as well key proteins that are 
relevant to the process.  
 
1.8. Impact and Significance 
A number of factors motivate the development of tools to further control T cell 
activation. Perhaps of paramount importance is the potential to treat diseases that have 
eluded traditional small molecule pharmacology. By harnessing the high specificity of 
immune cells, there is great ambition to cultivate immune cells in situ for use in 
personalized treatments that escape the limitations of small molecule-based strategies. 
Past pharmacological approaches could claim some small success towards improving the 
outlook for patients diagnosed with cancer. Likewise, cancer diagnosis often occurs too 
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late for substantial benefit from surgery; even in situations where the cancer is diagnosed 
during its onset, remission is an ever-persistent concern with surgical excision of 
metastases. Substantial improvements in cancer patient quality-adjusted life years 
[QALY] were first realized with the advent of monoclonal antibody therapies: one of the 
earliest instances of harnessing the immune system in a non-vaccination therapy. A 
deeper understanding of T cell activation and further work in the direction of 
immunotherapy will blur this difference between biotechnology and vaccine therapies in 
the encompassing field of cell-based therapies. A similar rationalization may be applied 
to the time and effort dedicated towards HIV. Though pharmacological drugs may deter 
the progression of the disease to the extent that CD4+ cell count is undiminished, they 
have been unsuccessful in enabling the immune system to recognize and eliminate the 
viral load. Moreover, these treatments require daily regimens, compounding both costs 
and adverse side effects. For both cancer and HIV, a number of promising successes have 
indicated that these aspirations are not baseless [33-38].  
 
The work entailed in this thesis seeks to buttress these successes by providing insight into 
what has made them successful. The subsequent chapters will focus on the CD28 
costimulation pathway that is critical for functional T cell differentiation. This work 
looks to resolve the process through which CD28 initially couples with TCR-based 
activation and deconstruct the pathway through which CD28 mechanically augments 
cellular activation. Moreover, this thesis will identify and characterize underlying 
differences in mouse and human primary CD4+ T cells that may be applied to more 
effectively bridge preclinical work with clinical trials.  
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2.1 Abstract     
 
APC-driven T cell costimulation involves the formation of a spatially complex synapse. 
Previous work has identified that the relative position of CD28 within the immune 
synapse drastically augments the secretion of IL-2 by mouse CD4+ T cells. In contrast, 
human cells fail to integrate TCR and CD28 signaling when segregated on the micron 
scale. Moreover, previous work demonstrates that mouse cells are sensitized to spatial 
segregation of these receptors through the immobilization of Cholera Toxin subunit B 
[CT-B] at the interface. The proposed mechanism for this extracellular manipulation of 
intracellular mechanics is the immobilization of cholesterol-rich regions, with which 
certain intracellular proteins associate. The observed disparities in high level function, 
IL-2 production, were also found to correlate with the distribution of the Src kinase Lck 
in its active form, which shows substantial distribution across the interface of mouse cells 
but remains highly colocalized with TCR activation in human cells. This chapter 
characterizes the role of Lck diffusion in differentially integrating TCR and CD28 
signaling, as well as the ability of CT-B to deter Lck diffusion in mouse cells. 
Cytoskeletal enrichment to the activating interface in the two systems reveals substantial 
differences. Human cells exhibit a more dense cytoskeleton at the IS than mouse cells 
and CT-B slightly augments the cytoskeleton of mouse cells. Disassembly of this 
cytoskeleton in human cells through chemical inhibition both modifies the diffusivity of 
Lck and desensitizes them to segregation of TCR and CD28 signaling. Together, these 
results demonstrate a reaction-diffusion model for regulating intracellular signaling 
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where both membrane dynamics and cytoskeletal restructuring play significant roles in 
relaying T cell activation. 
 
2.2 Introduction      
 
The immune synapse forms through the coordinated effort of both the T cell and its APC. 
Antigen presentation by the APC to the TCR designates it as the major coordinator of 
cellular activation and the centerpiece of the IS. However, TCR engagement is alone 
insufficient for cellular activation. For full elicitation of T cell activity, a costimulatory 
factor is required. CD28 was the first discovered costimulatory factor, and its engagement 
by APC receptors CD80 or CD86 complements TCR activation to produce a robust and 
profound response in the naïve T cell [39-41]. The synergism of the TCR and CD28 
pathways depends on numerous downstream components, the coordination of which can 
drastically skew the direction of cellular activation.  
 
Lck is known to play a significant role in the activation of both TCR and CD28 receptors. 
Upon TCR engagement, Lck is the first kinase to initiate tyrosine phosphorylation of the 
ITAM motif of CD3ε, enabling recruitment of Zap-70 and basal cell activation through 
the TCR. In addition to mediating activity of the TCR-CD3 complex, Lck also plays a 
role in enabling downstream signaling of CD28 through tyrosine phosphorylation of its 
cytoplasmic tail [42, 43]. The 41 amino acid cytosolic tail of CD28 mediates numerous 
functions, including but not limited to: altering cellular metabolism, activating 
transcription factors, inducing cytoskeletal rearrangement, polarizing cells towards TH2, 
circumventing anergy and cytokine secretion [44-46]. These processes, collectively, 
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signify CD28-based costimulation as a significant factor in the maturation of T cells and 
motivate research that delves into the processes involved to enable CD28-based 
costimulation. 
 
Previous work has demonstrated that mouse CD4+ T cells could respond to micrometer-
scale segregation of the CD3 and CD28 receptors, suggesting that Lck was capable of 
relaying costimulation even over long-range distances within the cell [24]. Human CD4+ 
T cells have also been revealed to be incapable of eliciting costimulation when receptors 
are separated in the same manner, affording an opportunity to assess the underlying 
mechanism of Lck-mediated costimulation through a study of the two systems. This 
concept of modulating cellular activation through manipulation of IS structure implicates 
that regulation of intermediate signaling molecules as key in conferring spatial 
sensitivity. Both regulation of lateral diffusion and protein phosphorylation states have 
been described as viable mechanisms in other systems [47-49]. Moreover, the 
significance of spatial interplay in the IS is not without prior merit. Previous work 
looking at T cell activation by B cells and DCs shows differential localization of the TCR 
with CD80, one of two binding partners on APCs that engage the T cell costimulatory 
receptor: indicating that different APCs differentially regulate the microscale segregation 
of the TCR with CD28 [18, 50]. In this aim, we focus on the CD4+ T cell and the 








Figure 2.1. Spatial Sensitivity to Costimulation. (A) IL-2 is measured at six hours in mouse CD4+ T cells 
on surfaces that target CD3ε and CD28 in colocalized (coloc) and segregated (seg) patterns. With a 
background composed of ICAM-1 and BSA (BSA), localization of CD28 to the periphery of the interface 
enhances secretion. However, when cholera toxin subunit B (CT-B) is used, secretion of IL-2 is severely 
curtailed on segregated surfaces. (B) Unlike mouse cells, human T cells show reduced IL-2 secretion at six 
hours upon segregation of CD3ε and CD28 signaling. The level of IL-2 secretion is comparable to surfaces 
that do not contain CD28. (C) Staining for active Lck, distinguished by phosphorylation at Tyrosine 394 
(pLck), shows differences in mouse and human cells on segregated surfaces. Whereas mouse cells (bottom) 
show a relatively homogenous distribution, human cells exhibit preferential localization of pLck with sites 
of TCR activation. Scale bar denotes 5 μm. 
 
Colocalization of CD3 and CD28 through microcontact printing result in relative high 
levels of Interleukin-2 [IL-2] secretion in murine T cells, though the spatial segregation 
of these two pathways resulted in substantially higher levels of secretion (Figure 2.1 A). 
Introduction of surface-immobilized CT-B reversed this trend: enhancing activation on 
colocalized features and substantially reducing the benefits initially conferred by 
separation of the two receptors (Figure 2.1 A). Though the precise mechanism is still 
under investigation, the application of CT-B as a stain for monosialoganglioside [GM1]-
rich regions suggests that cholesterol-rich regions of the membrane may be involved in 
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protein shuttling. Moreover, Lck preferentially associates with GM1, a process which is 
thought to dissociate Lck from its strong interaction with CD4 so that it instead migrates 
with GM1-rich membrane microdomain [51].  
 
Like mouse cells, human CD4+ T cells demonstrated high levels of IL-2 secretion on 
colocalized patterns. However, the spatial separation of the two receptors in human cells 
substantially reduced IL-2 secretion in the absence of CT-B treatment (Figure 2.1 B). 
Immunostaining for phosphorylated Lck provides strong correlative evidence that while 
active Lck localizes with both segregated TCR and CD28 in mouse cells, it is 
predominantly constrained to the site of TCR activation in human cells (Figure 2.1 C). 
Additional work will assess the mobility of Lck during cellular activation and seek to 
understand the underlying factors that contribute to this inter-species difference. 
 
2.3 Materials and Methods 
Surface Preparation. The preparation of micropatterned glass surfaces has been 
previously demonstrated and validated, both by this lab as well as others [24, 52, 53]. We 
recommend these cited literatures for details on fabricating these surfaces. Briefly, this 
process involves fabrication of the desired features through photolithography, and the 
application of soft lithography to transfer protein(s) of interest in structural patterns that 
conform to these features. Given the relative stability of antibodies, multiple rounds of 
transfer are possible within a defined space. This work applies at most two rounds, with 
the interest of segregating activation of the TCR and CD28 receptors to their respective 
antibodies using microcontact printing. Following patterning of antibodies targeting 
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CD3ε and CD28, the background of a patterned surface is backfilled with Fc-ICAM-1 
(R&D Systems, 720-IC-200) at a coating concentration of 2 μg/mL. For experiments 
where CT-B (Invitrogen, C-34779) was used to deter membrane mobility, either CT-B or 
BSA was mixed at  a 1:5 ratio with ICAM-1 for an effective concentration of 0.4 μg/mL. 
To ensure consistent coating and imaging techniques, glass coverslips were cleaned in 
200°C detergent (Linbro 7x, diluted with DI water to working concentration), rinsed in 
multiple rounds with MilliQ-purified water and subsequently baked at 415°C overnight. 
 
Cell Isolation and Culturing. Resting peripheral human CD4+ T cells were isolated 
from whole blood. Following venipuncture, primary lymphocytes were isolated from 
whole blood by Ficoll-Paque gradient (GM) using an Eppendorf 5810R swinging bucket 
centrifuge. CD4+ T cells were enriched from the lymphocyte layer by negative selection 
using Invitrogen Dynalbeads Untouched kit (Invitrogen 113-52D). Mouse CD4+ T cells 
were isolated separately from lymph nodes and spleens of C57BL/6 mice aged 6-8 
weeks. After an initial extraction through a 40 μm filter, CD4+ cells were enriched 
similarly to human CD4+ T cells, via negative selection using Invitrogen Dynalbeads 
Untouched kit (114-15D). 
 
CD4+ T cells were cultured in RPMI 1640 media supplemented with 10% FBS, 10 mM 
HEPES, 50 U/mL Penicillin & Streptomycin, 2 mM L-glutamine and 50 μM β-
Mercaptoethanol. For timelapse microscopy, phenol red was excluded from the media to 
minimize autofluorescent interference. For experiments, cells were cultured for 30 
minutes to eight hours at 37°C, 5% CO2; temperature and gas concentrations were 
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maintained using a LiveCell™ stage top incubation platform. Phenol-free RPMI 1640 
media was used during microscopy to minimize autofluorescence.  
 
For experiments involving F-actin destabilization through Latrunculin B [LatB], cells 
were given 15 minutes to bind to the surface prior to LatB treatment. A range of LatB 
concentrations, from 10 nm to 10 μm, were tested to discern a concentration that was 
effective at moderately destabilizing the cytoskeletal, permitting a notable effect without 
detracting from basal processes. These starting values were determined from the 
manufacturer product sheet as well as previously published literature using LatB in 
lymphocytes [54-56]. 
 
Antibodies, Proteins and Immunostaining 
Both human and mouse T cells were activated using monoclonal antibodies targeting the 
CD3ε chain of TCR and CD28. OKT3 and CD28.6 were used for human cells; CD3ε 
clone 145-2C11 and CD28 clone 37.51 were used to activate mouse cells. An Fc-ICAM1 
chimera was used for LFA-1 interactions. An Fc variant is ideal for our experimental 
setup, as its adsorption to planar surfaces can compete equitably with the TCR and CD28 
activating antibodies used. 
 
For measurement of CD4 diffusion, FAB regions were generated by using Pierce FAB 
microprepartation kit (Pierce, 44685). The use of the FAB regions permit a more transient 
binding duration than a traditional dimeric antibody, helping to mitigate artifacts induced 
through the labeling process. FAB regions were added to the cells following seeding at a 
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concentration of 100 nM. 
 
For immunostaining, cells were fixed with 4% paraformaldehyde for 10 minutes and the 
membrane then permeabilized with 0.1% Triton X-100 in phosphate-buffered saline 
[PBS] for 15 minutes. Antibodies targeting phosphorylated Lck Y394 (Novus Biologics, 
NBP1-60894), or total Lck (Cell Signaling, 2714) were used. Cells were also stained for 
with phalloidin (Invitrogen, A12379) to resolve F-actin.  
 
IL-2 Assay. Cellular activation is quantified in the context of the secretion of the 
cytokine IL-2: one of the key indicators of CD4+ T cell activation and a functional 
mediator of its effect on other cells once active [57, 58]. One of the advantages of using 
IL-2 as a proxy for cellular activation is early onset of IL-2 production following cellular 
activation. IL-2 is measured by indirect capture through a Miltenyi Biotec secretion assay 
which, through an indirect capture via the ubiquitous transmembrane protein CD45, 
allows measuring of IL-2 secretion on a cell-by-cell basis. This discretization permits a 
measurement of IL-2 on patterned surfaces in a manner that would be less robust via 
ELISA measurement. As per the protocol recommended by the manufacturer, cellular 
activation on microscale patterns began at six hours, which is adequate time for the cell to 
initiate substantial IL-2 secretion, and lasted for one hour. Thus, the rate of IL-2 secretion 
was measured for one hour, lasting from the 6th to 7th hour of cell adhesion. For 
experiments where IL-2 secretion was measured in LatB-treated cells, the 15 minute 
wash-in time was encompassed in the overall six hours. LatB was also applied during the 
subsequent hour of IL-2 measurement, as this study does not aim to quantify the recovery 
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process of LatB-treated cells. 
 
Nucleic Acid Transfection. The vectors used in this section include a construct for Lck 
appended to the fluorescent protein YFP, both in plasmid and mRNA form. DNA 
plasmid and mRNA based methods were both used and found to be robust. Transfection 
was performed using Neon Transfection System by Invitrogen. Following transfection, 
cells were permitted to recover in prewarmed RPMI 1640 media containing 10% FBS 
and 5mM L-glutamine. For plasmid-based transfection, cells were left to recover 
overnight, whereas for mRNA-based transfection, cells were left to recover for 5 hours 
before imaging. Experiments involving FRAP of transfected cells were given 15 minutes 
for initial adhesion and FRAP data was collected in the subsequent hour, except for 
instances where otherwise stated in the experimental design. 
 
Diffusion Measurement. Diffusion was measured via fluorescence recovery after 
photobleaching [FRAP] to gauge the recovery of a subcellular region across the glass-cell 
interface. Images were collected by Total Internal Reflection Microscopy [TIRFM]. 
TIRFM relies on a change in refractive index between a glass substrate and media to 
excite fluorophores that are within the vicinity of the interface: permitting a depth of view 
within 50-100 nm of this interface. Lck is a cytosolic protein that associates to membrane 
components; thus, TIRFM enables imaging of the membrane fraction of Lck while 





Data Acquisition and Analysis 
All images were collected using an Olympus IX81 inverted microscope equipped with 
objectives for imaging at 20x, 60x and 100x resolution. Images were collected using an 
Andor iXon3 EM-CCD for time-lapse microscopy and an Andor Neo cSMOS for high 
resolution microscopy. MetaMorph for Olympus was used for software acquisition of 
images. Image processing was predominantly performed with ImageJ v1.46, included but 
not limited to: overlaying multiple channels, measuring cell area and intensity, bleach-
correcting timelapses and generating montages. Where appropriate, certain functions of 
image analysis were performed in Matlab. 
 
Diffusion coefficients were measured using the Hankel transform, as described by Hook 
and colleagues [59]. This process makes use of the Hankel transform to calculate a 
weighted-sum of linear diffusion profiles radially distributed around the central point of 
bleaching. There are numerous benefits for calculating recovery by diffusion with the 
described method. In brief, these benefits include: independence from an analytic 
solution, reduced sensitivity to boundary conditions (relative to Fourier method), and the 
ability to resolve anisotropic diffusion. In the absence of anisotropic diffusion, a weighted 
average of the diffusion profile may instead be used. 
 
Statistical Analysis. Statistical analysis was performed using a number of techniques. A 
p-value of 0.05 was used unless stated otherwise. A t-test was executed on paired 
analyses. The validity of multiple comparisons was corrected for with Tukey’s range test. 
Data was recorded in Microsoft Excel 2011 and statistical analyses were performed in 
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Origin 8.0. Means reported in this thesis are followed with the 95% confidence value 
included in parentheses. All data is representative of at least two independent 
experimental runs, though in the interest of aligning with strict temporal parameters, 





Lck mobility correlates with spatial sensitivity 
To validate previously observed inter-species disparities, the bulk diffusion of Lck across 
the membrane was measured in mouse splenic and human resting peripheral CD4+ T 
cells. Cells were transfected with a plasmid containing Lck appended to a fluorescent tag, 
YFP, to measure Lck diffusion via FRAP. A visual example of this process, including the 
distribution of Lck prior to bleaching, the site of the bleached region and a timescale of 
the recovery, is demonstrated in Figure 2.2A. Employing this approach, Lck diffusion in 
human T cells was found to be 0.04 (+/- 0.01) μm2/s, showing a total recovery time from 
a 1 μm radial bleach spot on the order of 5-10 seconds. Duplicating this process in mouse 
cells demonstrated a much greater capacity for diffusion, with the diffusion coefficient 
for Lck was measured to be 0.37 (+/- 0.09) μm2/s (Figure 2.2 B). This disparity in 





Figure 2.2. Diffusion measurement. (A) FRAP is used to measure the diffusion coefficient in a mouse T 
cell. The pre-bleach frame shows the distribution of Lck at the surface interface. The subsequent frame 
shows the result of the subcellular photobleach, approximately 1 μm in diameter. The following frames 
show the following timelapse. Scale bar denotes 5 μm. (B) Human T cells show reduced mobility relative 
to mouse cells on homogeneously coated with anti-CD3, anti-CD28 and ICAM-1. Moreover, CT-B impairs 
the diffusion coefficient of Lck on surfaces. To keep these ligands at a constant concentration between the 
two conditions, the CT-B fraction was replaced with BSA in the (-) control. (C) The diffusion of CD4 was 
measured and showed similar diffusive properties as Lck. CD4 diffusion in human cells was measured at 
0.04 ± 0.01 µm 2/sec and 0.37 ± 0.09 µm2/sec in mouse cells. 
 
well with previous assumptions of a reaction-diffusion model and though it does not 
preclude a difference in phosphorylation dynamics, it does indicate that the diffusion of 
Lck is a major factor in the sensitivity of human T cells to spatial distribution of IS 
constituents. To further develop this model, we next looked at CT-B treated mouse cells, 
to see if this manipulation was successful in impairing the diffusion of Lck. Measurement 
of the diffusion of Lck in mouse cells when in the presence of CT-B led to a decrease in 
Lck diffusion, resulting in decreased mobility from 0.37 (+/- 0.09) to 0.07 (+/- 0.02) 
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μm2/s (Figure 2.2 C). This is consistent with a model where Lck diffusion is intrinsically 
deterred in human cells. Here, deterral of Lck diffusion through its interaction with GM1-
rich lipid subdomains reflects both a diffusion coefficient as well as a spatial sensitivity 
to segregation of receptors that is similar to human cells. Manipulation of surface 
membrane dynamics through surface-immobilized CT-B augments intracellular Lck 
diffusion in mouse cells. This suggests either intrinsic differences in the APCs that 
activate human and mouse T cells or a fundamental difference in human CD4 T cells that 
perturbs Lck diffusion. Further exploration of these two systems focuses on the 
intracellular mechanisms that regulate diffusion of Lck. 
 
Lck and CD4 exhibit a similar diffusion profile 
We next looked at the transmembrane protein CD4: the namesake protein for helper T 
cells. The spatial correlation between Lck and CD4 is well established [51, 60]. Of note, 
the high affinity of Lck for CD4 and CD8 is key in the maturation of thymocytes into T 
cells. This affinity is anticipated to persist in naïve T cells, though a difference in the 
relative diffusion of Lck and CD4 in human or mouse cells would do much to rationalize 
the disparate behavior of Lck in the two species. CD4 also plays a role in triggering the 
autophosphorylation of Lck into its active state, a function not achievable by TCR 
coupling alone [61]. Measuring the diffusion of CD4 in the two species demonstrated a 
similarity in the properties of CD4 and Lck in both human and mouse cells (Figure 2.2 B, 
C). These results support previous works that indicate the two proteins as co-receptors, 
but do not contribute to an understanding of what may be responsible for the difference in 
cellular properties of human and mouse cells. Rather, the similarities shared by these two 
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proteins implicate a more fundamental difference in the two species, compelling an 
investigation into the underlying cellular machinery that are responsible for cellular 
dynamics. 
  
Cytoskeletal Enrichment at the IS Differs in Mouse and Human T cells  
Triggering of the TCR leads to extensive actin polymerization, which plays a critical role 
in sustained interaction between the T cell and the APC [28, 62]. To further evaluate the 
role of the cytoskeleton in the immune synapse, mouse and human CD4+ T cells were 
activated on homogeneously coated activating surfaces after which both F-actin and 





Figure 2.3. Cytoskeleton differences in mouse and human lymphocytes. (A) Mouse and human CD4 T 
cells were stained for phosphorylated Lck [pLck] (red) and F-actin (green) on planar surfaces coated with 
αCD3, αCD28 and ICAM-1, revealing distinct differences between the two species at 30 minutes. Whereas 
mouse cells contained enrichment of these two proteins at the periphery of the cell and a moderately diffuse 
network in the cell center, human cells contain a dense network of both proteins. Treatment of human cells 
with 1 µm Latrunculin B destabilized the actin cytoskeletal, also manipulating the localization of pLck, 
which now shows greater colocalization with F-actin. (B) The intensity per unit area of F-actin was greater 
by a factor of two in human cells than in mouse cells. Treatment of human cells with 1 μm of LatB reduced 
the average intensity of the actin cytoskeleton. (C) Human cells show a greater interface area, roughly 
twice the area, than mouse cells. LatB treatment further increases the area of human cells. Together, these 
quantify the degree of cytoskeletal enrichment at the IS in human cells relative to mouse cells. 
 
revealed profound differences between the actin cytoskeletal in the two systems. Human  
T cells exhibited a homogenously dense cytoskeleton, rich in compact, overlapping 
filaments. Mouse T cell actin networks were instead characterized by enrichment along 
the periphery, to the extent that it severely masked low levels of actin in the central 
synapse. A direct comparison of the F-actin per area in the cell showed that human T 
cells polymerized more than twice the F-actin per area than mouse cells (Figure 2.3 B). 
Scaling for the size of the interface, as human T cells spread to an area twice that of 
mouse cells, demonstrated that the interface in human cells contained four times the 
amount of polymerized F-actin at the cell-surface interface than do mouse cells (Figure 
2.3 C).  
 
F-actin destabilization enhances Lck diffusion in human T cells 
To test whether the actin cytoskeleton plays a role in directing Lck diffusion, we 
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selectively inhibited F-actin assembly with the small molecule LatB. Immunostaining of 
LatB treated cells confirmed phenotypic changes induced by F-actin destabilization. F-
actin per area was substantially reduced, though total cell area was increased by roughly 
50%, perhaps due to the inability of the cell to retain contractility with reduced levels of 
accessible actin filaments (Figure 2.3 A-C). This LatB-modulated diffuse network also 
induced a change in the localization of active Lck. Untreated human cells exhibit a dense 
cytoskeletal network, largely masking the spatial coordination with a far less dense active 
network. However, T cells treated by LatB demonstrated a high level of correlation of 
active Lck with the residual F-actin, their correlation tentatively suggesting an active 
mechanism of Lck regulation by the cytoskeleton (Figure 2.3 A). This active regulation 
would be in contrast to a model where a dense actin cytoskeleton passively deters Lck 
mobility, which would manifest with a low degree of spatial correlation between the  
 
 
Figure 2.4. LatB desensitizes human cells to micropatterns. (A)  Treatment of human T cells with LatB 
increases the lateral diffusion of Lck along the membrane by a factor of 5. (B) Treatment of human T cells 
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with LatB during the first six hours of activation does not significantly affect IL-2 production on 
colocalized features. In the absence of LatB, IL-2 secretion on segregated surfaces is comparable to basal 
activation through CD3 alone. However, LatB treatment substantially increases IL-2 production on 
segregated patterns, bringing secretion levels on par to those of colocalized features. 
 
cytoskeleton and Lck. This low spatial correlation would be further reduced with the 
destabilization of the actin network. 
 
To validate the role of the cytoskeleton in limiting Lck mobility, we directly measured 
the diffusion of Lck in LatB-treated cells. LatB-treated human cells had a measured 
diffusion coefficient of 0.19 (+/- 0.02) μm2/s, compared to the 0.05 (+/- 0.01) μm2/s in 
untreated cells (Figure 2.4 A). This fivefold increase in the diffusivity of Lck indicates F-
actin plays a significant role in modulating its diffusion. Briefly comparing the diffusion 
profile of Lck in LatB-treated human cells and mouse cells, there is still roughly a two-
fold difference. The continued difference between LatB-treated human cells and 
untreated mouse cells suggests that the mechanism of F-actin destabilization in human 
cells does not perfectly reflect the mouse cytoskeletal network. Alternatively, other 
mechanisms of regulation are at play. This change in Lck diffusion in human cells, 
induced by LatB, warrants reinvestigating the capacity of human T cells to respond to 
patterns defined by segregation of TCR and CD28 triggering. 
 
F-actin destabilization desensitizes human cells to segregation of TCR and CD28 
To empirically test the previously observed correlation of Lck distribution and diffusion 
with human T cell sensitivity to segregated TCR and CD28, we measured the secretion of 
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IL-2 on these patterns in the presence of LatB. Using the same approach to quantify 
cellular activation by indirectly capturing IL-2 secretion, we measured the effects of LatB 
on both colocalized and segregated patterns. LatB showed little effect on colocalized 
features, suggesting that the concentration used to destabilize the actin cytoskeleton was 
sufficiently moderate to not augment IL-2 secretion (Figure 2.4 B). However, LatB 
treatment resulted in a profound difference on segregated patterns. Whereas untreated 
cells fail to couple CD3 and CD28 when these receptors are segregated, LatB treatment 
enabled coupling of segregated features and resulted in IL-2 production comparable to  
 
 
Figure 2.5. Latrunculin B modulates localization on micropatterns. (A) Staining for F-actin (green) on 
segregated patterns of antibodies to CD3ε (red) and CD28 (blue) shows a dense homogeneous distribution 
in untreated cells (top), whereas LatB treated cells (bottom) show moderate enrichment of F-actin at the site 
of TCR triggering and a more diffuse network throughout the interface. (B) Staining for active Lck on 
35 
 
segregated (left) and colocalized (right, shown in purple) features of CD3ε  and CD28 both showed 
predominant colocalization of active Lck at the site of TCR triggering in untreated cells (top). However, 
treatment of cells with LatB in both instances resulted in a more even distribution of active Lck along the 
cell interface. 
 
colocalized costimulation (Figure 2.4 B). These results implicate the cytoskeleton as 
responsible for both restricting Lck mobility and for the inability of human T cells to 
couple segregated activating receptor pathways. We next looked at the distribution of 
Lck, in its active form, on patterns to ensure that this response was indeed tied to the 
drastic change in IL-2 production in the presence of LatB. Staining for F-actin on 
segregated patterns validated that LatB leads to cytoskeletal depletion across the 
interface, though greater enrichment was observed near the site of TCR engagement 
(Figure 2.5 A). This is in keeping with previous models that point to the TCR as being 
responsible for the recruitment of F-actin to the interface [28, 63]. The distribution of 
active Lck also radically shifted in response to cytoskeletal destabilization. On both 
colocalized and segregated features, phosphorylated Lck showed extensive distribution 
throughout the cell in the presence of LatB, but remained localized to the site of TCR 
engagement in untreated cells (Figure 2.5 B). These results culminate this study into the 
role of Lck as a mediator of TCR and CD28 pathways: a process in which the 




Numerous models that describe immune synapse dynamics have been developed in the 
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interest of understanding the process of T cell maturation; many of these models share a 
number of key characteristics [51, 64-67]. In the interest of vetting these models, in 
addition to having a sound conceptual basis for exploring the integration of costimulatory 
signaling within the immune synapse, we have derived a number of critical experiments 
to artificially manipulate cellular regulation. These results implicate that costimulation 
through CD28 is subjected to regulation by Lck, which confers spatial sensitivity to the 
TCR and CD28 receptor systems. This regulation may be described in the framework of a 
reaction-diffusion model, where following Lck phosphorylation at the TCR, the extent of 
regulation of its mobility confers sensitivity to IS spatial structure. Our observations 
implicate cytoskeletal dynamics and likely lipid microdomain associations as facilitators 
in conferring cellular recognition to microscale organization of IS receptors. Moreover, 
impairment of F-actin assembly in human cells via LatB inhibition does not impact T cell 
activation on patterns where TCR and CD28 activation is colocalized; this suggests that 
the abundance of F-actin at the interface is present to serve a different purpose. The 
following chapters will look at mechanical force generation during cellular activation: a 
role that the actin cytoskeleton is aptly suited to facilitate. 
 
The work in this chapter also demonstrates that differences in mouse and human CD4+ 
naïve T cells responses to IS receptor segregation may be rationalized through the 
regulation of a mediator protein: in this context, Lck is characterized as being an ideal 
mediator. Human T cells restrict the migration of Lck through the development of a 
dense cytoskeletal network at the IS interface. This work does not directly resolve 
whether the mechanism of Lck regulation by the cytoskeleton is active or passive. 
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Immunostaining showing a correlation of the two in LatB-treated cells does suggest that 
there is a link between the cytoskeleton and Lck. This link, however, is not required in 
the context of a reaction-diffusion model: where the mode of diffusion may be either 
active or passive. This work does establish that destabilization of this network increases 
the diffusion of Lck and enables coupling of TCR and CD28 signaling across micrometer 
distances.  
 
The work in this chapter also demonstrates that this model also rationalizes the lack of 
sensitivity for spatial segregation exhibited by mouse T cells. Direct measurement of the 
lateral diffusion of Lck and immunostaining for its distribution demonstrate that Lck 
mobility across the IS is not hindered to the extent that it is in human cells: permitting 
crosstalk between the TCR and CD28 pathways across micron-scaled distances. 
Moreover, mouse T cells feature a less complex actin cytoskeleton at the interface, 
rationalizing this difference in sensitivity. Previous work using CT-B to limit diffusion of 
Lck across the interface is also validated to result in decreased migration of Lck and to 
lead to slight restructuring of the actin cytoskeleton at the interface. 
 
Given that substantial differences have previously been identified in IS formation and 
structure based on the APC that activates a T cell, we postulate that this insight into IS 
spatial complexity will prove advantageous. Our observed differences in mouse and 
human T cells builds on growing recognition that disparities between the two systems 
exist. Of particular note, Th17 cell derivation takes different chemical cues in mouse and 
human CD4+ T cells [68]. Th17 cells make for a compelling vehicle for adoptive 
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immunotherapy given their capacity to function even when faced by Treg suppression [69, 
70]. However, Th17 cells form a small subset of the CD4+ population; devising processes 
to more effectively cultivate Th17 would require careful management of activation cues 
in a manner that takes into consideration differences in the differentiation pathway of 








The activation of T cells is a mechanoresponsive process. Numerous labs have looked to 
evaluate the forces that are required in the initiation and persistence of the T cell and 
APC interaction [31, 71]. In this chapter, we employ traction force microscopy using an 
elastomer micropillar array as a template that enables both the activation of T cells and 
the measurement of the forces they exert during activation. This system enables the 
calculation of cellular forces through the tracking of micropillar displacements resulting 
from cellular exertion. Employing this system, we first quantify the forces that T cells 
exert on their environment during costimulation through the TCR and CD28. Next, we 
assess the capacity of CD28 to act as a mechanoresponsive receptor, which is shown to 
augment TCR-mediated force generation. Mapping this process demonstrates that CD28 
does not exhibit mechanosensitive properties, providing equivalent biophysical responses 
when presented in solution or on the surface material. An inhibitor-based study of the 
downstream components of CD28 is used to demonstrate that augmentation of TCR 
forces is mediated through PI3 Kinase but is upstream of the protein kinase Akt. 
 
Unlike the previous chapter, where parallels were drawn between human and mouse 
systems, human T cells are the sole focus here. The substantial and rich cytoskeletal 
network observed in human T cells makes them ideal candidates for a study of cellular 
forces. More relevant, human cells were the focus of work performed with collaborators, 
where the proliferative capacity of human T cells was found to be enhanced by 
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decreasing the stiffness of the underlying substrate [72]. The work in this publication is 
limited to planar PDMS which, as a copolymer of two viscous materials, has practical 
limitations on the minimum stiffness that can be achieved. This chapter circumvents this 
practical limitation by using a discontinuous interface to substantially reduce this 
modulus, studying the behavior of T cells at a modular range that is more representative 
of its interaction with an APC. 
 
3.2 Introduction 
The previous chapter focuses on the signaling molecule Lck as an intermediate in 
harmonizing TCR activation with CD28 costimulation. The actin cytoskeleton was found 
to play a significant role in regulating the diffusion of Lck, conferring spatial sensitivity 
to segregation of TCR and CD28. Previous work has looked at the TCR interaction itself 
and characterized its sensitivity to force exertion: in which the actin cytoskeleton likely 
plays a significant role [31, 71]. Using IL-2 as an early indicator of cell activation, 
Judokusomo et al. have recently demonstrated that mouse CD4+ T cells differentially 
respond to the underlying rigidity of an activating surface. Though the TCR and CD28 
work in unison towards cellular activation, the response to rigidity was relayed through 
the TCR pathway. These observations describe the summation of the first six hours of 
cell activation: an early time point when compared to T cell function following 
activation, but a time point that is downstream of the dynamics that initiate activation 
processes. This work characterizes the capacity of TCR to act as a mechanoresponsive 
receptor: playing a role in the differential transformation of a mechanical stimulus into a 




One further step in understanding this process is to capture the process through which 
differential forces impart multifarious responses. A single protein that is responsible for 
identifying and dynamically responding to the rigidity of the underlying substrate is 
characterized as mechanosensitive. In the correlation of surface rigidity and six hour IL-2 
secretion, it is difficult to characterize which protein is responsible for this trend. TCR 
and CD28 are the primary sites of engagement though for both receptors, either 
downstream constituents or another system acting in parallel may be responsible for this 
rigidity response. In this direction, we look to characterize cellular processes early on in 
cellular activation. Cell activation is initiated upon receptor engagement, and a large 
number of downstream intermediaries, such as Zap-70 phosphorylation, MTOC 
relocalization and Ca2+ flux happen within the first half hour of initial contact [73-75]. 
This chapter aims to use these early endpoints to assess cellular activation during the first 
hour of engagement. Moreover, whereas previous work has used cellular activation as an 
endpoint to study the effect of surface forces, this chapter aims to use cell-generated 
forces as an endpoint to assess cellular activation.  
 
Force-sensing systems have previously been used as a platform to characterize cellular 
forces in fibroblasts and smooth muscle cells [76, 77]. Control over a large number of 
parameters, including substrate material, pillar diameter, pillar height and pillar spacing, 
enables relatively precise measurements of cellular behavior using a metric that is not 
easily captured by most in vitro systems: force exertion. This chapter will look at the 
response of CD4+ T cells to activation through the prism of mechanical forces. The 
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significance of this measurement has previously been articulated, where surface rigidity 
was shown to modulate IL-2 secretion in mouse cells. However, past work into the 
structure and nature of the IS has focused on metrics that have been more easy to 
quantify, such as the nature and organization of the proteins involved. The IS is a 
physical interaction between two cell types, each of which recruits a substantial 
cytoskeletal network to induce IS formation and retention of this interaction. Past and 
current techniques have enabled the identification of a majority of the key proteins 
involved in T cell activation; current work seeks to better characterize protein interactions 
and pathways. In this chapter, we first aim to directly measure cellular force generation as 
a function of time during TCR-driven and CD28-mediated activation. We subsequently 
hone in on the CD28 receptor pathway and map the mechanisms through which it 
physically augments TCR engagement.  
 
3.3 Materials and Methods 
Fabrication and Substrate Preparation. Masters for micropillar arrays were designed 
using the general template designed by the Chen lab [76, 78]. Pillars were designed to be 
1 μm in diameter and were arrayed in a hexagonal formation with 2 μm center-to-center 
spacing to ensure equispaced proximity among neighboring pillars. Pillars of heights 3 to 
9 μm were fabricated. Negative molds were cast in PDMS (Sylgard 184, Dow Corning) 
from these masters, silanized overnight with (tridecafluoro-1,1,2,2,-tetrahydrooctyl)-1-
trichlorosilane (United Chemical Technologies) and used to cast pillar arrays directly 
onto thickness #0 Fisherbrand glass coverslips that were cleaned as previously described. 
To avoid the collapse of high aspect ratio pillars, surfaces were submerged in 99% 
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ethanol prior to release from their PDMS mold. The ethanol was then slowly replaced 
with DI water and eventually PBS containing activating antibodies that were used to coat 
the surface. Cast pillar arrays were assessed by SEM for vertical sidewalls and uniform 
pillar dimensions. 
 
Antibodies, Proteins and Immunostaining. Human T cell activation was achieved 
using OKT3 and CD28.6 as previously described. For timelapse microscopy, FAB regions 
of anti-CD45 Alexa488 (Biolegend, 304019) were used to track the cell membrane. 
These FAB regions were generated by using Pierce FAB micropreparation kit (Pierce, 
44685), previously described, and added to the cells prior to seeding at a concentration of 
200 nM. Cells were immediately seeded on pillars following the addition of FAB CD45. 
FAB regions were maintained in solution throughout imaging. 
 
Cells were fixed and immunostained as previously described. Antibodies used in this 
section were used to target CD45 (Biolegend, 304019), phosphorylated Zap70 Tyr 319 
(Cell Signaling, 2701S), phosphorylated Pyk2 Tyr 402 (Invitrogen, 44-618G), non-
muscle Myosin IIA (Abcam, ab24762), Filamin A (Abcam, ab51217) and α-tubulin 
(Invitrogen, 322588). 
 
Protein Inhibition. Latrunculin B, at a 1 μm concentration, was used to test the role of 
actin assembly in force generation. Likewise, the role of non-muscle Myosin IIA 
contractility was tested through the use of Blebbistatin (Sigma-Aldrich) at a 
concentration of 10 μm. The role of PI3K in mediating CD28-enhanced contractions was 
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tested by its inhibition with a wortmannin conjugate, wortmannin 17β-hydroxy analog 
[HWT]. HWT was preferentially used for selective PI3K inhibition over wortmannin due 
to its greater potency and specificity in targeting PI3K. To ensure that the role of PI3K 
assessed is downstream of CD28, rather than the TCR itself, we test HWT inhibition of 
PI3K in both the presence and absence of C28 costimulation. Akt, the downstream 
effector of PI3K that is thought to be responsible for initiating IL-2 secretion, is tested by 
inhibition via triciribine (Tric). 
 
Data Acquisition. For tracking pillar displacements, timelapse stacks were bleach-
corrected with a custom script for ImageJ and realigned via the StackReg plug-in 
developed by BIG at EPFL [79]. Pillar traces were then generated using the Particle 
Tracker plug-in developed by Mosaic at ETH [80]. Traces were then saved as text files, 
and imported into Matlab where background pillars were identified and cellular force 
measurements were calculated using a custom script. Relevant outputs that were collected 
include the average force per pillar, number of pillars in contact, and the total force per 
cell. An additional custom script was used to superimpose a vector map of the forces over 




T cells exhibit multiple, discrete phases of engagement 
Human CD4+ T cells seeded on micropillar arrays coated with activating antibodies were 
used to measure forces, schematized with the model below (Figure 3.1 A). T cell 
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behavior was qualitatively characterized and noted to exhibit a range of behaviors that 
could be roughly separated into discrete phases. Cells made contact with the top of the 
microarray in a manner similar to contact with a continuous surface, rapidly spreading 
after initial contact to cover numerous pillars (Figure 3.1 B1-2). This spreading process 
did not result in significant traction forces, suggesting that any future displacements were 
an active process and not the result of a change in the cell center of mass. After some 
time of stabilization, cells began to exert forces in an uncoordinated fashion, exhibiting 
individual pillar displacements that were unsynchronized in both magnitude and direction 
(Figure 3.1 B3). After a sustained period of uncoordinated displacements, which typically 
lasted in the range of five minutes to half an hour, cellular contractions slowly gained 
more uniformity, showing greater displacements along the periphery of the cell and 
largely being directed centripetally (Figure 3.1 B4). Once in this uniform contractile 
phase, abrupt changes in direction and magnitude mitigated, though total force exertion 
remained relatively constant. Cellular forces were measured throughout this process, 
during which the displacements of individual pillars were tracked and the relative forces 
exerted by the cell on them measured. Actively displaced pillars were distinguished from 
pillars not displaced by the cell through the identification of conserved movement across 
the entire system, which was comprised of minor perturbations in the stage and ambient 
drift. The forces exerted were calculated over time and used as a metric for calculating 
the force exerted by the cell (Figure 3.1 C). Forces exerted by T cells on micropillar 
arrays were calculated to be on the order of 58 (±22) pN/μm2, with a total force of 1.23 




Figure 3.1. T cells exert forces on micropillar arrays (A) A 2D schematic shows the typical interaction of a 
T cell (blue) with the antibody-coated micropillar array (red). The displacement due to cellular exertion, δ, 
is used to calculate the force generated as described in Section 3.2. (B) Four time points that correspond to 
discrete phases are numbered and shown in (C). In (1), a cell as it first makes contact with the micropillar 
array.  After initial contact, the cell rapidly spreads (2) while exhibiting minimal contractile force. Cells 
then initiate force generation on the micropillar array (3) by initially applying unsynchronized contractile 
forces, marked by white arrows. Finally, cells reach a stable equilibrium (4) where the greatest force 
exertion occurs along the cell periphery and are oriented towards the center of the cell. Scale bar in C4 
denotes 5 μm. (C) A plot of T cell force exertion over time, where each solid trace represents an individual 
pillar. The blue traces are pillars that are not in contact with the cell, whose ambient movements are tracked 
and used to remove the contribution of ambient drift from forces generated. The red traces show the 
interactions of the cell with individual pillars. The dotted cyan line shows the average force exerted on each 
pillar by the cell, whereas the dotted green line represents the total force exerted by the cell, scaled by 5 so 






T cell contractile forces are conserved across differing rigidities 
To ensure that the forces measured were descriptive of cell behavior; contractile forces 
for cells on costimulated surfaces were measured on pillar arrays of differing effective 
Young’s moduli. Pillar diameter was kept constant at 1 μm diameter, so as not to impact 
contact area, and T cell force generation was measured on pillars of varying heights of 3 
to 9 μm. This approach has previously been used to demonstrate that epithelial cells 
maintain a constant displacement, rather than a constant force, when interacting with soft 
pillars of differing stiffness [81]. Pillars of heights 5, 6, 7 and 8 μm were all found to give 
reliable and consistent measurements. Below 5 μm, pillar displacements were too 
nominal to be measured precisely and at 9 μm, pillars were displaced to the extent that 
neighboring pillars would come in contact, making it difficult to accurately measure the 
total force involved in displacements. This behavior, where the degree of displacement 
varied with the stiffness, was a preliminary indication that displacements were not 
conserved in T cells. To ensure that forces were conserved, forces measurements were 
carried out on pillars of heights 5, 6, 7 and 8 μm, which respectively represent  effective 
stiffnesses of 2.4, 1.4, 0.9 and 0.6 nN/μM. Forces generated by T cells were found to be 
conserved across this range (Figure 3.2 black). Moreover, cell spreading area was not 
found to be statistically different across these tested pillar heights (Figure 3.2 red). It is 
worth noting that these surfaces span a four-fold change in stiffness. Previous work that 
evaluated IL-2 secretion spanned a much wider range of stiffness, 3-5 orders of 
magnitude, and thus this conservation of force across micropillar heights does not 
discount that T cells can generate differential forces across a wider range of stiffness. 
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Thus, while this range may not be suitable for evaluating the effect of rigidity, the range 
tested here is appropriate to show that force generation, rather than pillar displacement, is 




Figure 3.2. Cellular force exertion across pillar heights. T cell forces were measured across a range of 
pillar heights, 5-8 μm, that represent a four-fold change in stiffness. Force per area, indicated in black, was 
found to be consistent across this stiffness range. Likewise, the number of pillars that a cell was in contact 
with, indicated in red, was also conserved across this stiffness range, indicating that both force per area and 
total cellular force were conserved. Data is representative of >3 experimental runs. Means are plotted, with 
error bars representing the standard deviations for both force per area and pillars in contact. 
 
behavior is suggestive of a different mechanism of generating and sustaining forces in T 
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cells than in epithelial cells.  
 
To further characterize this behavior, we tested inhibition of the cytoskeletal network. 
Work highlighted in the previous chapter illustrated that the cytoskeleton played a 
significant role at the immune synapse and functioned in regulating protein diffusion. The 
role of the cytoskeleton in generating forces was tested here using the same approach of 
inhibiting F-actin assembly through LatB-based inhibition. LatB was effective at 
abrogating cellular forces, demonstrating that in addition to being responsible for 
regulating lateral diffusion along the membrane, the cytoskeleton is critical in generating 
cellular forces. To see whether force generation relied on myosin activity, non-muscle 
Myosin IIA contractility was inhibited through the application of blebbistatin. 
Blebbistatin functions by impairing Myosin ATPase activity and thus prevents myosin-
induced force generation. Blebbistatin treatment of cells also led to abrogation of cellular 
forces, indicating that both actin and myosin, though likely a combination of actomyosin 
contractility, leads to T cell force exertion on micropillars. Staining for cytoskeletal 
constituents show enrichment of F-actin at the points of contact with the micropillars, 
whereas Myosin IIA showed moderate depletion from these regions (Figure 3.3 A). 
Previous work in the direction of understanding the molecular pathways involved in the 
generation of contractile forces has relied on loss-of-function point mutations [82]. The 
relative depletion of Myosin IIA from the regions of contact was somewhat unexpected. 
The significance of this displacement from the site of force exertion is not fully 
understood, but may be rationalized in the context of the functional distance needed to 
induce myosin contractility. Non-muscle Myosin IIA functions in multiple capacities, 
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including cellular protrusions, adhesion disassembly and nuclear relocalization  [82]. 
These numerous roles occlude the resolution needed to make a more definitive assertion 
on the displacement of Myosin IIA from the contact regions of cellular contact with 
micropillars. 
 
Figure 3.3. Protein enrichment on micropillars. (A) Cytoskeletal constituents F-actin (top, green) and non-
muscle Myosin IIA (bottom, green) are stained for in T cells seeded on micropillar arrays. The activating 
coating, antibodies that activate CD3ε and CD28 (red) is imaged at the interface of the top of the 
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micropillars with the T cell. (B) The active forms of activating factors Zap70 and Lck are stained for. Scale 
bars denote 5 μm. 
 
Having established that the fundamental components were in place for force generation, 
we next looked to ensure that T cells were being activated, and thus the noted forces were 
a response to cellular activation. The active, phosphorylated populations of Lck (Y394) 
and Zap70 (Y319) were stained for determine cellular activation; the active form of Lck 
has been covered in depth in the previous chapter. The active form of Zap70 is used as a 
proxy for TCR triggering, its phosphorylation both following and being dependent upon 
Lck activity at the TCR [73, 83]. Both Zap70 and Lck showed substantial enrichment at 
the regions of the cell interface in contact with micropillars, suggesting that activation 
through the TCR had been initiated (Figure 3.3 B). In the previous chapter, we describe a 
mechanism for the integration of CD28-mediated costimulation with the TCR pathway. 
The remainder of this chapter builds on the role of costimulation, and looks at the 
contribution of CD28 in the context of cellular forces.  
 
Costimulation through CD28 enhances T cell contractile forces 
The force measurements taken so far describe the effects of cellular activation when both 
TCR and CD28 are engaged. To measure the impact of CD28 triggering on force 
generation, we compared force generation on surfaces that triggered TCR activation, both 
in the presence and absence of CD28 triggering. Forces were measured using the pillar 
aspect ratios that were previously described and revealed that the inclusion of CD28 
costimulation increased contractile forces from 0.70 nN to 1.26 nN per cell: an increase 
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of over 80% (Figure 3.4). Neither cell spreading area nor the number of pillars interacted 
with were observed to differ due to CD28 activation. As discussed earlier, CD28 
costimulation modulates a wide range of factors, including increasing the sensitivity of a  
 
 
Figure 3.4. CD28 activation augments cellular forces. This graph describes the role of CD28 in mediating 
TCR forces. Inclusion of CD28 activation, either on the coating surface or in solution, equally increases T 
cell contractile forces. Forces measured here represent the total force exerted by a cell through micropillars. 
Pillar contact area is not augmented by the inclusion of CD28, either in solution or on the surface, and thus 





T cell to antigen engagement, inducing a greater rate of proliferation and a significant 
increase in IL-2 secretion. However, the capacity of costimulation to modulate cellular 
forces has not been previously described. We anticipate that this augmentation of cellular 
forces is facilitating one or more of these other processes. To resolve the role of this 
increase in activation forces, we next characterized the pathway through which CD28 
acts to augment force generation. 
 
CD28 triggers IS mechanoresponse, but is not mechanosensitive 
To better characterize the mechanism involved in CD28 modulation of cellular forces, we 
next assess the capacity CD28 acts as a mechanosensitive receptor; testing for 
mechanosensitivity requires a method of differentially targeting the TCR and CD28. 
CD28-based costimulation was relocalized from surface presentation in parallel with 
TCR stimulation, where the underlying rigidity of the substrate would be responsible for 
a mechanoresponse, to in-solution targeting of CD28, where the strength of the 
interaction would rely only on antibody binding affinity. After initial coating of 
micropillar arrays with TCR-activating antibodies, residual binding sites on the surface 
were blocked with 4% BSA for one hour. Cells were then seeded with activating 
antibodies to CD28 introduced in-solution, permitting interaction of the antibody with 
CD28 in a manner independent of surface properties. Delineating the presentation of 
CD28 from on the micropillar array with CD3 targeting antibodies to in solution did not 
show a notable change in force exertion or behavior (Figure 3.4). That the two methods 
of CD28 activation were equally effective suggests that while costimulation was a 
mechanoresponsive process, the CD28 receptor was not the key mechanosensitive 
54 
 
mediator of the response. Rather, an internal mechanism for increasing contractile forces 
was likely responsible for the change.  
 
 
CD28 activation differentially augments protein enrichment 
The process of activation-induced force generation was previously found to be fully 
dependent on cytoskeletal activity; inhibition of either actin or non-muscle myosin IIA 
both led to abrogation of cellular forces. This was true in both the presence and absence 
of CD28 activation, inclining us to postulate that the CD28-mediated mechanoresponse 
also required the activity of these two cytoskeletal components. Costimulation has been 
shown to stabilize membrane condensation at sites of TCR activation, leading us to look 
at constituents that were known to preferentially associate with CD28 over the TCR [84].  
 
We first looked to measure whether CD28 impacted TCR triggering. Activation of CD28 
either through surface presentation or in solution both showed comparable levels of 
phospho-Zap70 localization, suggesting a mechanism downstream of Zap70 recruitment 
to the TCR and likely downstream of CD28. In keeping with this theme of 
mechanoresponse, we quantified the relative enrichment of key cytoskeletal components 
at the pillar array (Figure 3.5). F-actin was seen to increase with the incorporation of 
CD28 activity: in agreement with an increase in contractile forces and LatB-based 
inhibition of F-actin abrogating cellular forces. Interestingly, the behavior of myosin IIA  
was unchanged; rather Filamin A was modulated by CD28 costimulation. Filamin A was 




Figure 3.5. CD28 modulates cytoskeletal enrichment. (A) Filamin A did not show preferential localization 
on micropillars when the TCR was triggered (top). However, Filamin A was depleted from micropillars, in 
a manner similar to Myosin IIA, when CD28 was added to the surface coating (bottom). The relative 
intensities of pillar surface coating, Filamin A and CD45 are tracked along the white line in the Merged 
figures, and the distribution of protein is shown on the right. (B) The effect of CD28 activation was 
measured on Myosin IIA, Filamin A, CD45 and F-actin by Pearson correlation. Whereas Myosin IIA 
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distribution was unaffected by the inclusion of CD28 activation, Filamin A showed a negative 
colocalization with the micropillars, indicated by a Pearson value less than 0. Moreover, while CD45 was 
unperturbed, F-actin showed increased localization to micropillars in the presence of CD28.  
 
perplexing given a known linkage between Filamin A and CD28. These results achieved 
through immunostaining yield additional insight into the physical manipulations through 
which increased forces may be generated. However, they do not describe the pathway 
through which CD28 signaling triggers increased contractile forces. Filamin A is a 
compelling candidate for this role, as it does bind directly to CD28 and links to the actin 
cytoskeleton. Though, the relative depletion of Filamin A from sites of CD28 
engagement suggests that its predominant role in this process is not through direct 
linkage with CD28. Thus far we have shown that CD28 is mechanoresponsive but not 
mechanosensitive, indicating that there is a downstream pathway to mediate this 
mechanoresponse. We next looked to PI3 kinases that, like Filamin A, interact directly 
with CD28 but also have a well-characterized pathway and available chemical methods 
of manipulation. 
 
PI3K relays CD28-mediated contractility 
Phosphatidylinositol 3-kinase [PI3K] directly associates with the YMNM motif on the 
cytosolic tail of CD28, helping propagate costimulation and making for a compelling 
mediator for relaying changes in contractile forces [39, 85, 86]. The PI3K pathway is a 
major though not exclusive intermediary for CD28 costimulation. Its roles include Akt 
and PDK1 recruitment through D3 lipid production, PKCθ recruitment to the immune 
synapse and Akt phosphorylation [85, 87, 88]. Previous work has shown that disrupting 
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the PI3K interaction to CD28 via a mutation of the binding site does not impair IL-2 
secretion, unlike a disruption in the Src-kinase binding PYAP domain of CD28 [89].  
Inhibition of PI3K was achieved using a wortmannin conjugate, 17β-
Hydroxywortmannin [HWT], which was used for its higher selectivity for PI3K. As a 
secondary target, wortmannin binds and inhibits mammalian target of rapamycin 
[mTOR], which plays an active role downstream of PI3K. Numerous proteins within this 
pathway are considering key targets in the dissemination of cancer [90]. Cells were 
seeded on micropillars and given 15 minutes to initiate contact. HWT was subsequently 
washed-in at a concentration of 50 nM and contractile forces were measured. On 
costimulatory surfaces, contractile forces were reduced to 0.82 (+/- 0.06) nN as a result of 
treatment with HWT (Figure 3.6). To ensure that PI3K inhibition by HWT was directly 
affecting costimulation, and not instead responsible for forces generated through TCR-
based activation, we subsequently applied HWT to cells activated exclusively through the 
TCR. TCR-dependent force generation was unaffected by HWT inhibition, generating 
forces of 0.69 (+/- 0.07) nN, suggesting PI3K plays a role in mediating a CD28 
mechanoresponse (Figure 3.6). We next looked at a downstream target of PI3K, Akt, 
whose role in costimulation is tied to long-term IL-2 production. Inhibition of Akt via 
triciribine, using a post-adhesion wash-in method as previously described, did not impact 
cellular forces generated on costimulatory surfaces (1.29 +/- 0.11 nN), suggesting that 
though Akt directs long-term IL-2 secretion, it does not play a role in generating cellular 
forces during the first hour of activation (Figure 3.6).  
 
Finally we targeted PDK1 which plays a significant role in triggering a number of 
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downstream protein kinases [91]. Though much effort has gone into identifying selective 
inhibitors of PDK1 for targeting cancer metastasis, few candidates have been identified. 
The novel inhibitor GSK 2334470 [GSK] has been touted as highly selective [92-94]. We 
tested the effects of PDK1 inhibition with GSK at a concentration of 10 nM. Within 15 
minutes of GSK wash-in, cells abated contractile forces in a manner similar to what was 
previously observed with LatB treatment of contractile cells. Together, selective 
inhibition of PI3K and PDK1 suggest that while PDK1 is critical for forces generated 
through the TCR and CD28, the role of PI3K is to integrate CD28 costimulation. 
 
 
Figure 3.6. PI3 Kinase mediates forces through CD28. CD28-dependent contractile forces were tested by 
selective inhibition of its downstream pathway. PI3 kinases were inhibiting using the more selective 
wortmannin conjugate 17β-Hydroxywortmannin (HWT), which mitigated the contractile forces generated 
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through CD28 but had no effect on cells activated through CD3 alone. Inhibition of Akt, which is further 
downstream of PI3 kinase, with Triciribine (Tric) has no effect on cellular force generation. Inhibition of 
PDK1 with the novel inhibitor GSK 2334470 (GSK) abrogated cellular forces entirely, which is denoted by 
an asterisk (*). 
 
3.5 Discussion  
The results in this chapter highlight a number of key findings. First, it highlights and 
demarcates the mechanoresponsive role of CD28 in IS dynamics. CD28 is known to 
dramatically influence T cell response through a number of intermediates, leading to 
substantial ramifications on T cell fate and function. We demonstrate here that CD28 
relies on its downstream constituent PI3K to convey modulation of mechanical forces 
independent of TCR-triggered force generation. Though Akt is downstream of PI3K 
activity, it does not contribute to force generation. PDK1, however, plays an essential 
role in TCR-mediated contractile forces. A number of proteins probed in these 
experiments show preferential localization, some uniquely through CD28 such as Filamin 
A, and others more broadly. Future work will look to further characterize this preferential 
localization with the interest of developing a model for force generation. Importantly, this 
work will also seek to resolve how PDK1 loops back to the cytoskeletal network.   
 
The work in this chapter demonstrates that changes in contractile forces during T cell 
activation can be captured and accurately measured through the use of micropillar arrays: 
providing micron resolution on cellular forces. This is not the first instance of complex 
topologies being used to explore T cell activation, though we anticipate that the findings 
presented above will facilitate future efforts to identify how cellular forces are 
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coordinated with T cell activation. We consider both the mechanism of force generation 
through the IS as well as the role of the CD28 in the process to be compelling. It is worth 
noting some aspects of CD28 behavior during costimulation, which may illuminate its 
role in mechanoresponse. Following CD28 engagement, it is endocytosed in a clathrin-
dependent fashion through the coordinated efforts of PI3K and a number of proteins 
associated with vesicle formation and the cytoskeleton. The significance of CD28 
endocytosis in the context of costimulation is still an unresolved question. CD28 is the 
sole costimulatory ligand to be constitutively expressed on the surface of a T cell, though 
its presence on the surface does recede as the cell matures. Whether this endocytotic 
behavior correlates with increased cellular forces remains to be tested. The work in this 
chapter does not exclude this prospect, which would be in keeping to the observed global 




Chapter 4 – T Cell Activation Demonstrates Multiphasic Behavior 
 
4.1 Abstract 
In this chapter, we employ a number of techniques to characterize changes in T cell 
behavior that are triggered by cellular activation. Micropillar arrays are again employed, 
though here they are used to capture morphological changes following the first hour that 
was the focus of the previous chapter. After exerting contractile forces for roughly the 
first hour, T cells manifest an invasive morphology, where they relocalize from the top to 
the base of the pillar array. Cells that have relocalized to the base of micropillar arrays 
are capable of producing IL-2, indicating that they are still undergoing activation. T cell 
invasion is also shown to coordinate with MTOC and phospho Zap70 Y319 
relocalization, providing further evidence that T cell invasion does not preclude their 
activation. In concert with T cell relocalization, there is also substantial cytoskeletal 
reorientation and the redistribution of focal adhesion proteins. Finally, the motivation for 
the change in T cell morphology is examined, and through use of selectively coated 
cellular trenches, the formation of filopedia-like protrusions is found to be triggered by 
TCR activation. Activating cells probe these nonactivating regions through filopedial 
protrusions, but do not fully enter these trenches that lack TCR activation. Finally we 
look to put the forces and behavior of T cells observed in this and the past chapter in 
context. This is executed by assessing the mechanical properties of bone marrow-derived 





4.2 Introduction  
Upon maturation, the roles of a T cell include the monitoring of peripheral tissues by 
identifying and responding to the specific antigen that it has been primed to target. 
However, the ability of T cells to monitor these regions relies on their ability to access 
peripheral tissues that are remote to the vascular system. The walls that line vascular 
structures are densely packed with multiple endothelial layers, the function of which is 
intended to maintain fluid pressure and flow. This function would be compromised by 
cell-size gaps that would facilitate immune cell passage. Rather than the vasculature 
containing such gaps, it is more rationale to postulate that lymphocytes utilize a unique 
process of passing vascular structures with minimal structural damage. There currently is 
a compelling model that demonstrates a stepwise process through which T cells 
transmigrate past tissue layers to enter peripheral tissues [95, 96]. These tissue layers are 
not homogenous, and are often composed of different cell subpopulations with varying 
differential receptor expression and mechanical properties. Collectively, these 
requirements indicate that T cells are hardwired to penetrate through a number of discrete 
tissue layers: a feat that is anticipated to take a greater force and plasticity than what was 
measured during IS formation in the previous chapter. 
 
The previous two chapters focused on the process of IS formation and maturation: 
identifying key pathway components that modulate costimulation. Other research groups 
have also looked at ways to study the processes and significance of the IS. One approach 
to studying the IS has involved demarcating temporal phases of IS formation by changes 
in spatial protein localization at the interface [23, 67]. The benefit of such an approach is 
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that IS cues often follow such a temporal timecourse: where there are key events that 
must take place before the IS can mature to the next temporal phase. Others have instead 
attempted to integrate the behavior of the activating APC with that of the T cell: focusing 
on one or two key protein interactions and their direct downstream events [41, 97]. The 
aim of this chapter is to further characterize the interaction of a T cell with its activating 
surface, utilizing some features of these two models. In the previous chapter, we highlight 
the use of micropillar arrays in capturing cellular forces. During this early phase of 
cellular contractility on a costimulatory surface, T cells rest on the top of the micropillar 
while exerting contractile forces. In this chapter, we look at the long-term behavior of T 
cell on costimulatory micropillars, where they demonstrate the capacity to recognize and 
respond to the complex topology that these micropillars provide: leading to migration 
into the micropillars towards the base of the array. 
 
4.3 Materials and Methods 
Fabrication and Substrate Preparation. In addition to the micropillar masters that were 
previously described, masters for cell trenches were also employed. Work with bmDCs, 
which exhibit greater contractile forces than T cells, necessitated fabrication of 1 by 4 µm 
micropillars. The fabrication process was similar, and made use of 1μm μPG101 
Heidelberg laser writer to directly pattern SU-8 2005 photoresist.  
 
The same approach was used in the fabrication of cellular trenches. Positive molds were 
fabricated with laser lithography to be 1 µm in diameter and 5 µm deep. Negative molds 
were cast in PDMS (Sylgard 184, Dow Corning) from these masters, silanized overnight 
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with (tridecafluoro-1,1,2,2,-tetrahydrooctyl)-1-trichlorosilane (United Chemical 
Technologies) and then used to cast trenches directly onto thickness #0 Fisherbrand glass 
coverslips that were cleaned as described previously.  
 
Cell Isolation and Culturing. Resting peripheral human CD4+ T cells were isolated and 
enriched from whole blood as previously described. Immature mouse bone-marrow 
derived dendritic cells [bmDC]s were isolated by Subhashini Srivatsan (Shaw lab, 
Washington University in St. Louis) from mouse bone marrow following standard 
protocol [98, 99]. These cells were then matured for 6-8 days using RPMI-1640 media 
supplemented with 10% Hyclone serum and 2% Granulocyte-Macrophage Colony-
Stimulating Factor [GM-CSF], at which point they were seeded on fibronectin-coated 
micropillar arrays. Force generation was then measured as described in the previous 
chapters. 
 
Antibodies and immunostaining. Cell fixation, permeabilization and immunostaining 
were all performed as previously described. For comparisons of contractile cells with 
invasive cells, time points where the three phases manifested were used to directly 
compare protein localization. The ideal timepoint for capturing the three phases was 
heuristically determined to be at 3 hours. The behavior of contractile cells at 3 hours was 
compared to their behavior during the first hour and was not found to be substantially 
different. 
 
Characterization of cell behavior on micropillars. Cell behavior was characterized by 
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intermittent imaging of cells maintained at 37°C and 5% CO2 rather than tracking the 
behavior of one field of view over time. This was done to ensure that a large fraction of 
the population was captured. Three runs were performed using both TCR activating 
surfaces and TCR-CD28 activating surfaces, each with at least 50 timepoints. The 
inclusion of CD28 was not found to augment cell behavior over time. 
 
IL-2 secretion and statistical analysis. IL-2 capture and quantification was performed 
using the methodology described in Chapter 2. Here however, secretion was measured 
from 12 to 13 hours, rather than from 6 to 7 hours. The motivation for this deviation was 
to ensure that the majority of cells had entered the invasive phase, which occurs after the 
initial 8 hours of activation. Experiments were repeated threefold and statistical analysis 
was performed as previously described. 
 
4.4 Results 
T cells exhibit temporally-coordinated phases on 3D substrates 
T cells were captured exerting a dynamic range of forces during the half hour of 
activation on micropillar arrays. By the end of this half hour, a majority of T cells were 




Figure 4.1. T cell morphology over time. (A) T cells exhibit multiple distinct phases on activating 
micropillars. The initial contractile behavior where force measurements are taken (left) is later replaced by 
an intermediate phenotype (middle), where cells extend filopedial projections to interface with the surface. 
After some time, cells fully relocalize to the base of the array (right):, exhibiting an invasive phenotype. 
Scalebar represents 5 μm. (B) Tracking cell behavior and classifying them into these three phases over time 
shows that the majority of cells exit the contractile phase by 8 hours following initial activation. Scale bars 




We next looked to characterize whether cells in this contractile phase could maintain 
cellular activation, and thus were stable, or if dynamic force exertion would again 
resume. Following a prolonged period of stagnancy, cells began to exert filopedia-like 
protrusions that were observed extending both parallel to and protruding into the 
micropillar array. Over time, these protrusions stabilized as they made contact with the 
base of the array. As time progressed, T cells relocalized from the top of the pillars to the 
base of the array, eventually centralizing their contact and aligning to the base of the 
array. This relocalization was tracking through timelapse and three distinct phases were 
identified (Figure 4.1 A). During the first hour of cellular activation, T cells exert 
contractile forces on the top of the array. T cells then extend filopedia-like protrusions in 
an intermediate phenotype where the cell is monitoring its environment and while 
predominantly on the top of the micropillars, they may make contact with the base of the 
array. In many cell types, this monitoring behavior is tasked to the cilia; however, 
primary cilia have not been identified in lymphocytes, though these filopedial protrusions 
seem to serve a similar role [100-102]. Once these filopedia made contact to the base of 
the array, the cell began to migrate to the base of the array, in a phenotype described as 
invasive. Unlike the previous contractile phase, where forces were displaced towards the 
central region of the cell, invasive protrusions displaced pillars away from the cell’s 
center of mass. This change in direction was taken to be indicative of, and later correlated 
to, the relocalization of the cell to the base of the array. Quantification of the forces 
needed for this process was not feasible with our current set-up. Contractile forces have 
so far been calculated using a modification of the cantilever equation, in which one of the 
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underlying assumptions is that forces are exerted at a specified known height. For 
invasive cells, where there is extensive contact between the cell and the sides of the 
pillar, there is no direct method for assessing the distribution of force. Nor can it be 
assumed that forces are equally distributed along this region of contact.   
 
It is evident that greater forces are required to fully displace micropillars for cellular 
invasion. However, the extent of this difference in force generation is not directly 
measured. Rather, we apply a qualitative analysis of cellular behavior by classifying cells 
into these three phases, contractile, intermediate and invasive, and assess the progress 
through these phases over time.  Quantification of cellular phases over time showed that 
by three hours, roughly half of the cells had stopped exerting contractile forces on the top 
of the pillar array and had either proceeded to an intermediate or invasive phenotype 
(Figure 4.1 B). By six hours, the majority of cells had proceeded to an intermediate or 
invasive phenotype with roughly half in each of these two phases. The time-dependent 
migration of T cells into micropillar arrays was unexpected. The sensitive state of pre-
activated T cells, where failure to successfully form an IS and activate results in anergy 
and prompts cell death, led us to subsequently access whether these invasive cells were 
successfully activating. 
 
Cellular Invasion Impacts Activation 
Previously we identified protein localization in cells exerting contractile forces on 
micropillars. The relocalization of proteins critical to costimulation, the active forms of 
Zap70 and Lck, suggested that contractile cells were capable of initiating cellular 
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activation. However, the relocalization of the cell following the initial contractile phase 
led us to question whether invasive cells were in a state that could be considered 
 
 
Figure 4.2. Invasive cells are activated. IL-2 measurements from 12 to 13 hours after seeding demonstrate 
that invasive cells are capable of secreting IL-2. The level of secretion was comparable between 
micropillars of 1.7 kPa (5μm) and 0.3 kPa (9 μm), though both secreted roughly one half of adjacent cells 
that spread on regions of planar PDMS (2 MPa stiffness). 
 
activating. In addition to substantial structural reorganization, T cells physically contort 
their shape in an effort to make contract with the base of the array. T cell activation in 
vivo is predicated by the successful interaction of a T cell with an activating APC. 
Howerever it is unlikely for such an interaction to form and sustain for the desired 
timeframe without assistance.  One of the roles of high endothelial venules [HEV] within 
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the lymph node is to facilitate this T cell-APC interaction [103-105]. T cells enter HEVs 
through a multistep process similar to what is observed with their invasion into 
micropillars. The majority of T cells on micropillars had exited the contractile phase by 
eight hours, so we looked to measure the ability of T cells to secrete IL-2 after this time 
point. One hour IL-2 secretion was measured, as previously described, by indirect capture 
at 12 hours: sufficient time to ensure cellular invasion. IL-2 of invasive cells was 
measured and compared to cells activating on the planar PDMS regions adjacent to the 
micropillars. These planar regions were an ideal internal control as all temporal, cell 
quality and protein level factors were identical except for the changes introduced by the 
micropillars. Additionally, we measured the effect on IL-2 secretion of both 5 µm and 9 
µm micropillars, to resolve whether the effective stiffness of the micropillars may 
account for a difference in cellular activation.  Though no difference was noted between 
5 µm and 9 µm micropillars, both demonstrated roughly half the level of secretion as 
adjacent cells that were activating on planar PDMS (Figure 4.2). The noted reduction in 
IL-2 induced by the micropillars may be accounted for by a number of factors. It is 
possible that the process of relocalizing to the base of the microarray delays activation 
processes and thus the level of cytokine production is representative of a cell that has 
spent less time activating. This would indicate a delay in an interm process, as early 
indicators pointed to the initial triggering of the TCR and CD28 receptors. Alternatively, 
the micropillars may augment the activation process during the first hour, possibly 
through a change in the effective stiffness or due to the discontinuity of the activating 
surface. There is strong precedent, both from the perspective of T cell differentiation and 
for the development of other cell types, where early programming can have a profound 
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effect on long-term differentiation [106-111]. Cells that invaded into micropillars were 
found to still be capable of dividing on roughly the same timescale as those on planar 
surfaces, with the majority of cells undergoing mitosis 35-40 hours following initial 
activation. Collectively, these results suggest that cellular activation is initiated on 
micropillars and T cells later proceed through division, indicating successful 
programming by artificial APC. 
 
Phase change coordinates with protein relocalization 
To further resolve whether there was delayed or impaired activation of cells that had 
invaded into micropillars, we considered a number of critical IS maturation steps. Two 
discrete intermediate events that are required for IL-2 production, our metric of choice, is 
MTOC relocalization to the activating surface and NF-κB nuclearization. Microtubules 
are credited for a number of general tasks ranging from the retention of cellular structure, 
polarization of effector molecules, receptor endocytosis and maintenance of actin-
dependent structures [65]. Specific to IS maturation, the microtubule organizing center 
[MTOC], a morphologically distinct site of microtubule nucleation, plays a critical role 
during the activation of T cells by APCs. During activation, the MTOC relocalizes from 
the uropod to the cell-surface interface within minutes of sustained contact, from where it 
facilitates in the activation cascade pathways [112]. This process occurs soon after IS 
formation, generally within the first five minutes of adhesion, and is observed when T 
cells are activated by either APCs and by planar artificial substrates: making it an ideal 
candidate for an interim IS maturation metric. NF-κB translocation to the nucleus occurs 
later during IS maturation. Upon translocation to the nucleus, NF-κB stabilizes IL-2 
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mRNA, promoting its production and subsequent secretion, making it another strong 
candidate for an interim, though somewhat later, maturation metric [87, 113, 114]. 
 
T cells were immunostained to assess whether there was MTOC relocalization at 15 
minutes on both TCR-activating and costimulatory surfaces. This staining revealed that 
the MTOC failed to localize to the cell interface on the expected timescale (Figure 4.3, 
left). As shown in the previous chapter, however, the active forms of both Zap70 and Lck 
did localize to the regions of costimulation during this scale (Figure 3.3). Rather than 
repositioning within minutes as occurs on planar surfaces, less than 10% of the cells  
 
Figure 4.3. The position of the MTOC is tracked and found to be coordinated with the movement of the T 
cell to the base of the array by staining for β-Tubulin (green). In contractile cells (left) the MTOC delays in 
its movement to the site of activation, and is located in the region between the mid and upper cell. In 
invasive cells (right) the MTOC relocalizes to the base of the array, and is located between the pillar base 




exhibited a relocalized MTOC after initial contact. Our previous work indicated that 
cellular invasion was initiated following the first hour of contractile behavior. Fixing 
cells at three hours, to capture invasive cell behavior, indicated that invasive cells did 
exhibit a relocalized MTOC (Figure 4.3, right). 
 
To further characterize differences in behavior of contractile and invasive cells, we 
tracked the localization of phosphorylated Zap70 Y319 in invasive cells; MTOC 
relocalization indicated that the IS had repositioned to the base of the array and thus TCR 
engagement may be localized to the base of the array as well. Immunostaining for 
phosphorylated Zap70 Y319 in invasive cells demonstrated relocalization to the base of 
the array, while still retaining punctate form (Figure 4.4 A).  In keeping with the interest 
of resolving cellular activation components and cytoskeletal components, the localization 
profile of both F-actin and Myosin IIA were evaluated in invasive cells. F-actin 
demonstrated enrichment along the cell periphery, showing the greatest level of 
enrichment at the sites of cell contact with the sidewalls of micropillars. Myosin IIA did 
not show any preferential localization, though was noted to be present throughout the cell 
and not just enriched at the interface like with contractile cells. We next looked into the 
motivation for the invasive behavior. Both biochemical and mechanical properties are 
potential factors in driving cellular behavior, and the two would need to be deconstructed 




Figure 4.4. Protein redistribution in invasive cells. (A) Staining for TCR activation, indicated by 
phosphorylated Zap70 Y319, shows a relocalization of activating signal to the base of the array. (B) 
Staining for F-actin cytoskeleton showed distribution along the cell periphery, with substantial enrichment 
at the points of contact with micropillars. (C) Non-muscle Myosin IIA remains relatively diffuse 
throughout cells, though is physically segregated from the site of F-actin and CD45 enrichment along the 
perimeter. 
 
Cell activation drives morphology 
T cells that migrated to the base of the array exhibited a large degree of stability, which 
was impressive given the force exertion required to maintain displacement of the 
micropillars. Similar behavior has been observed in T cells as a function of their role as 
migratory cells. As previously described, T cells routinely penetrate through cell layers 
for a number of tasks, such as entering HEVs in the lymph node for activation by 
dendritic cells and passing through vascular endothelial layers to monitor peripheral 
tissues [115-118]. However, with the possible exception of HEV entry, these 
circumstances do not demonstrate transmigration in the presence of TCR activation. 
 
Rather, an intricate multi-step pathway initially triggered by integrins, such as LFA-1 and 
VLA-4, and chemotactic cytokines that drive lymphocyte transmigration. To resolve 
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whether the observed invasive behavior of T cells was a result of topology or TCR 
activation, we looked for a way to isolate the TCR signal from the topology. Past 
literature, as well as work earlier in this thesis, point to soft lithography as a valid 
mechanism of selectively distributing protein. However, the high aspect ratio of the 
micropillar array made attempts to transfer of protein to the top of the pillars unreliable, 
as these features readily collapse under pressure. To this effect, we designed trenches, 
which would provide the topology necessary to enable cellular migration but with 
sufficient bulk to withstand the process of physically transferring protein.  
 
Figure 4.5. TCR activation induces morphological changes. T cells were activated on cellular trenches, 
where the planar top regions were coated via microcontact printing with either CD3 (left image, blue) or 
poly-L-lysine (PLL, right image, blue). The base and sides of the trenches were then backfilled with BSA 
(red) to ensure that any behavior pertaining to the trenches would be motivated by topology rather than 
protein interactions. Cells that were activated with CD3 ±CD28 extended filopedial protrusions into these 
trenches, as indicated by an actin stain (green). However, cells that were coated on PLL did not exhibit 
similar protrusions. 
 
We applied selectively coated trenches to explore the driving force for T cell invasion 
into pillar arrays. To this effect, we compared the effects of transferring either activating 
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signal, targeting TCR ± CD28, or non-activating, poly-L-lysine [PLL], to the top of the 
surface, leaving the sides and bottom of the trench free of any coating. These regions 
were subsequently blocked with 5% BSA. Cells were seeded on these surfaces, where 
adhesion may occur at the top of the surface, and observed for morphological changes. T 
cells initially aligned with the direction of the trenches on both activating and non-
activating surfaces, indicative of a preference to maximize contact area. Fixing and 
immunostaining cells at three hours, a timepoint chosen for the mixed behavior of T cells 
on micropillars, revealed that T cells on activating surfaces were capable of extending 
filopedia-like protrusions into these trench regions when triggered by TCR activation 
(Figure 4.5). These filopedia, like those in cells penetrating micropillars, were rich in F-
actin. However, cells that were seeded on PLL did not generate these protrusions or show 
any effort to interact with the trenches.  
 
These results collectively suggest that the transmigratory-like behavior noted on 
micropillars was in part driven by activating signal and also in part by surface topology. 
The introduction of the filopedial protrusions were a direct consequence of cellular 
activation. Likewise, the topology provided by both the micropillars and trenches enabled 
cellular migration in a manner that would be difficult to capture on a planar surface. 
Collectively, these works suggest that the characterization of a dynamically stable IS may 
be an artifact of work performed on lipid bilayers, where the bilayer offers a planar 





T cells experience forces during activation 
T cell invasion into micropillars was an unanticipated outcome of TCR triggering. 
Moreover, the use of trenches demonstrated that actin-rich filopedial protrusions were 
triggered by activation. We next looked to put these results in context; earlier in this 
chapter, micropillars were applied to measure the forces exerted by T cells on their 
environment. Here we assess the mechanical properties and behavior of dendritic cells to 
gauge the forces exerted by an APC during IS dynamics. 
 
Bone marrow-derived dendritic cells [bmDC] were cultured with granulocyte 
macrophage colony-stimulating factor [GM-CSF]: a standard process for deriving mature 
bmDCs. Mature bmDCs were then briefly characterized on planar fibronectin-coated 
surfaces and were subsequently evaluated for contractile forces in a process similar to 
what was used for measuring T cell forces (Figure 4.6 A,B). BmDC behavior was notably 
different than CD4 T cells; rather than exhibiting numerous phases, bmDCs went through 
an initial spreading phase, leading to a burst of force along the perimeter, and 
subsequently showed the greatest displacement along the perimeter of the cell. Like T 
cells, bmDCs forces, rather than displacements, were conserved across pillars of varying 
stiffness (Figure 4.6 C). The forces generated by bmDCs, however, were substantially 
larger than T cells, averaging 11.5 nN per cell, or 320 pn/μm2. The results here are more 
tenuous, as they are measured when bmDCs are engaged by integrins, rather than by an 
interaction that is intended to directly simulate a T cell interaction. Unlike T cell receptor 
engagements, which have been successfully simulated with activating monoclonal 
antibodies, there has been less motivation to replicate the interaction from the APC side. 
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Future work may look to see if these noted forces are retained during T cell engagement.  
 
 
Figure 4.6. Measurement of bmDC forces (A) A representative image of a bmDC generating forces on 5 
μm pillars, along with (B) the accompanying brightfield image. (C) Measurement of bmDC forces across 
pillars of different spring constants demonstrated a behavior similar to T cells, where force generation 





Studies that look at T cell activation using planar glass substrates have been integral in 
the identification of key proteins that are relocalized during IS maturation; moreover, 
these studies have validated that T cell activation may proceed using artificial APCs. The 
subsequent application of lipid bilayers and the temporal resolution of protein migration 
through photoconjugated fluorescent tags have together led to insights into the spatial-
temporal dynamics of T cell activation: pinnacled by the bull’s eye alignment of 
activation factors. In this chapter, we expand on previous works by using 3-D topology to 
characterize cell behavior, both with respect to cell migration and protein localization 
over time. After an initial phase, lasting roughly one hour, of exerting contractile forces 
on micropillars, T cells begin to extend filopedial projections to identify the topology of 
their environment. These protrusions were precursors for the relocalization of the cell to 
the base of the array. Using fabricated microtrenches, we identify that while these 
protrusions are initiated by TCR activation, cellular relocalization is driven by TCR 
engagement. The overall behavior of transmigration appears to deter cellular activation, 
leading to a delay in MTOC localization to the activating surface as well as decreased 
production of IL-2 relative to a planar surface.  
 
There is some overlap between these findings and those previously described by Husson 
et al, where a single protrusion from the cell is observed exerting forces on a TCR-
activating bead [31]. Here however, we demonstrate that these protrusions are initiated by 
TCR activation but do not extend exclusively towards the site of TCR engagement. 
Mapping of bmDC forces demonstrate that T cell plasticity is not without purpose. 
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BmDCs, and likely other APCs, demonstrate the ability to exert substantially greater 
forces than T cells, suggesting that the freely diffusing lipid bilayers that are used to track 




Chapter 5 – Conclusion 
 
5.1 Summary 
This body of work applies a range of techniques that collectively are used to investigate 
the subcellular processes that drive CD4+ T cell activation. The primary focus is a 
subcellular study of CD28-driven costimulation, where both the initial pathway enabling 
its coupling with TCR signaling as well as a number of its downstream endpoints are 
described. Coupling of the TCR and CD28 pathways is mediated by the Src kinase Lck, 
which is regulated by its protein interactions and the cytoskeletal network. The regulation 
of Lck diffusion in human T cells confers spatial sensitivity to the relative positions of 
TCR and CD28. The sensitivity observed in human cells is not shared in mouse cells that 
are sourced and purified in a comparable manner, and Lck plays a less significant role in 
conferring spatial sensitivity to the relative positions of TCR and CD28 in mouse T cells. 
Rather, previous work points to the relative distribution of CD28 across the interface, 
independent of TCR distribution, as the driving force in augmenting cellular activation in 
mouse cells [24]. The significance of this finding has not been resolved in vivo, but we 
postulate that this sensitivity imports significance during the formation of the immune 
synapse, where microclusters of TCR and CD28 comigrate to the central region of the 
synapse and later segregate within this central region. Modulation of spatial control 
through the cytoskeleton may either play a role in restricting TCR-CD28 communication 
when coclustered or may also be a mechanism to enable communication with the local 
depletion of actin from the central synapse. Cytoskeletal depletion in the context of this 
latter concept would share a similar, though not necessarily redundant, role as CD45 
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displacement towards the peripheral of the synapse.  
 
The work in this thesis also highlights the role of the TCR in enabling contractile forces, 
as measured on micropillar arrays. Costimulation through CD28 is found to augment this 
process; introduction of this costimulatory interaction increases contractile forces by a 
substantial level. Force measurements via micropillar arrays is also used to identify the 
role of CD28 as a mechanoreceptor. Triggering of CD28 enhances contractile forces 
through a process that is not dependent on its manner of presentation, highlighting its role 
as a mechanoresponsive but not mechanosensitive receptor. Given the complexity of the 
CD28 pathway, there are numerous routes through which this mechanoresponse may be 
mediated. We highlight that this augmentation is dependent on the role of PI3 kinase and 
its interaction with the cytoplasmic pathway. Moreover, PDK1, downstream of PI3 
kinase, is responsible for forces generated through both the TCR and CD28 pathway. 
This is a substantial first step in the mapping of this newly classified mechanoresponsive 
receptor. 
 
Work assessing the process of T cell activation on micropillar arrays also demonstrated 
the intricacy of the activation process; the ability to interact with an artificial substrate of 
complex topology revealed a new facet to T cell behavior. Whereas studies that activate 
of T cells on planar surfaces show the T cell to be relatively immobile during activation, 
micropillars introduce a new direction of cellular migration, into the array, which cells 
actively pursue in spite of the increased forces needed to pursue this direction of motion. 
Spatially segregating the topology from the activating signal, through cellular trenches, 
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demonstrates that TCR triggering is sufficient to initiate the extension of filopedia-like 
protrusions that T cells use to explore the topology of their environment. 
 
5.2 Future Directions 
 
Force-measuring bilayers 
While the micropatterning techniques applied provide the aforementioned insights into 
spatial dynamics, new studies are needed to resolve the temporal relevance of induced 
activation. The immobilization of proteins provided by micropatterned surfaces currently 
offers a compliment to work with lipid bilayers, where T cells may drive the localization 
of proteins within the synapse with little resistance. Micropillar arrays were used to 
quantify the forces generated during cellular activation, which were shown to be 
substantial. This approach of analysis using two dichotomized systems has its uses, but 
ultimately comes with the caveat of never fully capturing a truly representative 
environment.  Future work in this direction may seek to find a compromise between the 
two: where there is greater resistance to protein relocalization than what lipid bilayers 
currently permit. Past work on corralled bilayers has shown success in deterring the rate 
of membrane diffusion. Though nonlinear in relationship, controlling the gap size and 
spacing of corrals would be a functional method of regulating lateral diffusion, a process 
that can be overcome through increased force exertion. Application of corralled bilayers 
to the study of immune synapse formation may lead to new insights into the mechanics of 
TCR and CD28 integration, and the role of increased contractile forces induced by CD28 
to this process. Corralled bilayers permit the fluidity of membrane reorganization without 
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the compromise of free mobility; rather modulating the gap size and spacing enables the 
control of resistance to lateral flow. 
 
Cytoskeletal redistribution in lieu of depletion 
Also in the direction of spatial sensitivity to TCR and CD28 integration, the actin 
cytoskeleton was demonstrated to be largely responsible for the deterred diffusion of Lck 
in human T cells. The spatial correlation of Lck and F-actin in LatB treated cells also 
implicated that Lck diffusion is actively regulated. However, immunostaining for the 
cytoskeleton of cells invading micropillars revealed substantial F-actin enrichment along 
the periphery, in contact with the micropillars, whereas TCR triggering was localized to 
the base of the array. This demonstrates an alternative approach, other than LatB-induced 
inhibition of F-actin assembly, where the dense cytoskeleton is relocalized from the IS 
rather than deconstructed throughout the cell. We postulate here that relocalization of the 
cytoskeleton through similar techniques will desensitize human T cells to segregation of 
TCR-CD28 triggering. IL-2 secretion was measured, and demonstrated lower levels of 
secretion in invasive cells than those on planar PDMS; however, invasive cells on 
micropillars form smaller synapses than those on planar surfaces. Previous work has 
demonstrated that the breadth of the IS plays a significant role in IL-2 secretion. 
 
Vetting preclinical models 
There is also a need to further resolve and expand upon observed differences in human 
and mouse cells, where both the diffusion of Lck and the extent of F-actin enrichment at 
the interface differ. Work in this direction may be multifaceted but ultimately will be 
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driven by practical significance, which is to develop more precise models in the context 
of clinical endpoints. Early work has showed that the response to rigidity is 
fundamentally different in activating mouse and human T cells. Whereas human T cells 
show increasing levels of IL-2 production on softer surfaces, mouse T cells demonstrated 
increasing levels of IL-2 production on stiffer surfaces. However these experiments were 
not initially performed with the intention of a direct comparison. Both the methods and 
range of surface stiffness tested differ slightly, encouraging a more direct approach in 
comparing the responses. It would also be incumbent to propose a mechanism for this 
underlying difference. The cytoskeletal network, which was noted to exhibit fundamental 
differences in the two species, makes for a compelling candidate. 
 
A role for rigidity becomes significant in preclinical studies, where the properties of cells 
cultured on plastics may vary substantially from those that are derived in vivo.  
 
Pathways to costimulation 
The family of T cell costimulatory factors is categorized by protein receptors that interact 
with B7 proteins on the APC to augment T cell activation. Two B7 proteins, B7.1 & 
B7.2, were identified nearly twenty years ago: predating cluster differentiation [CD] 
nomenclature [119, 120]. Though these two proteins, now respectively named CD80 and 
CD86, have been well-characterized, the few differences that have been found do not 
drastically dichotomize the two [121-125]. Though current research indicates that the 
APC-side of costimulation exhibits nuanced differences, the T cell-side of the interaction 
has greater diversity in receptors that collectively manifest a multifarious response that 
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relies on expression levels and kinetics. The work in this thesis focuses exclusively on the 
CD28 pathway and its involvement in augmenting TCR activation. However, CD28 is 
not the exclusive costimulatory receptor; rather it is the most studied receptor. The family 
of T cell costimulatory receptors also includes cytotoxic T lymphocyte antigen 4 [CTLA-
4], inducible costimulatory molecule [ICOS], BTLA and PD-1. Along with CD28, ICOS 
acts as a positive costimulatory factor.  
 
The remaining three receptors, CTLA-4, BTLA and PD-1, play a role in negative 
modulation cellular activation: effectively terminating cellular activation, which inhibits 
T cell proliferation and leads to apoptosis [126]. Of the three, CTLA-4 was the first to be 
identified and is currently the most extensively studied. Recent work by Yokosuka et al. 
looks at the kinetics of CD28 and CTLA-4 competition for B7 interaction, demonstrating 
real-time competition between the two ligands that result in changes in spatial 
localization within the IS [127]. Here, CTLA-4 overexpression was found to block 
localization of CD28-PKCθ microclusters to the central IS: effectively abrogating 
positive costimulation through CD28. While it has been known for some time that 
CTLA-4 has a higher affinity for B7 ligands than CD28, this insight into a mechanism 
that manifests through spatial replacement of CD28 for CTLA-4 motivates exploration 
into the spatial regulation of CTLA-4 negative stimulation. The aims in this thesis, 
identification of a mechanism for spatial regulation of CD28-induced costimulation and 
an exploration into the role of mechanotransduction in costimulation, provide a 
framework for deconstructing the process of negative costimulation. Other than their 
intended endpoint for T cell differentiation, another fundamental difference between the 
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two receptors is their localization in resting naïve T cells. Whereas CD28 is constitutively 
expressed on the cell membrane, CTLA-4 is retained internally and is transported to the 
surface as T cell activation initiates.  
 
5.3 Significance 
Over the past few decades, the field of immunology has matured along with our 
understanding of the mechanisms that modulate the immune system. The dual roles of 
responding to foreign antigens and self-tolerating native tissues is a daunting task. Helper 
T cells play a distinct and critical role in immunesurveillance, as is evident in situations 
where their function or numbers are compromised such as with HIV. The work in this 
thesis introduces new metrics to assess T cell activation, which may be used to better 
characterize the impact of compromised CD4 T cells. Future work may look to 
reintroduce HIV-resistant CD4 T cells through the application of CARs that pervade 
CTLA-4 assisted viral infection. 
 
One of the underlying concepts of this thesis is subcellular organization: both in regards 
to its construction and its manifestation. That cells construct complex domains is well 
characterized in many systems [52, 53]. Here we focus on the IS junction between a 
mature APC and a naïve T cell to demonstrate a mechanism for pathway convergence 
that is driven by spatiotemporal dynamics. The work in this thesis develops a model 
where the convergence of two pathways can be spatially regulated by the diffusivity and 
regulation of an intermediate. Development of such models affords opportunities to study 




Though indications of disparities have existed for some time, it is becoming increasingly 
clear that what we consider to be our most robust preclinical models harbor nuanced 
differences that may ultimately misdirect our clinical endeavors. The rising cost of new 
drug approval has been marginally impacted by updated guidelines by the FDA that aim 
to minimize adverse effects. Rather, one of the greatest sources of high drug costs is late-
stage failures. The cost of taking a typical drug from identified substance to NDA 
approval has an average cost of $300 million. However, adjusting this price tag with the 
cost of failed INDs raises the average cost to $1 billion per drug. Advances that map the 
shortcomings of our preclinical models would do much to help reduce these costs. Efforts 
to further humanize mouse models, much in the same way that mouse-derived 
monoclonal antibodies have been humanized to reduce the immunogenicity of antibody-
based therapies. Already, extensive research has gone towards the development of these 
humanized mouse models for specific disease categories [128-130]. Future work in this 
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